On Semiconductor Corp 10-Q for FY2020 Q2
On Semiconductor Corp (ON)
10-Q
2020-08-10
For: 2020-07-03
View Original
Added on
April 07, 2026
About this 10-Q
On Semiconductor Corp filed this 10-Q on August 10, 2020, covering the quarter ended July 3, 2020 (FY2020 Q2).
Headline figures
Quarter ended July 3, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.21B
- down 10.0% from $1.35B a year earlier
- Net loss
- $1.4M
- compared with net income of $101.8M a year earlier
- Diluted EPS
- $0.00
- compared with $0.24 a year earlier
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||
For the quarterly period ended July 3, 2020
Or
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||
For the transition period from to
(Commission File Number) 000-30419
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||
(602 ) 244-6600
(Address, zip code and telephone number, including area code, of principal executive offices)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
| N/A | ||||||||
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act
☒ | Accelerated filer | ☐ | |||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | |||||||||
| Emerging growth company | |||||||||||
If emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No x
The number of shares outstanding of the issuer's class of common stock as of the close of business on August 5, 2020:
| Title of Each Class | Number of Shares | |||||||
| Common Stock, par value $0.01 per share | ||||||||
ON SEMICONDUCTOR CORPORATION FORM 10-Q
TABLE OF CONTENTS
| Part I: Financial Information | |||||||||||
| Item 1. Financial Statements (unaudited) | |||||||||||
| Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations | |||||||||||
| Item 3. Quantitative and Qualitative Disclosures About Market Risk | |||||||||||
| Item 4. Controls and Procedures | |||||||||||
| Part II: Other Information | |||||||||||
| Item 1. Legal Proceedings | |||||||||||
| Item 1A. Risk Factors | |||||||||||
| Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | |||||||||||
| Item 3. Defaults Upon Senior Securities | |||||||||||
| Item 4. Mine Safety Disclosures | |||||||||||
| Item 5. Other Information | |||||||||||
| Item 6. Exhibits | |||||||||||
| Signatures | |||||||||||
(See the glossary of selected terms immediately following this table of contents for definitions of certain abbreviated terms)
ON SEMICONDUCTOR CORPORATION
FORM 10-Q
GLOSSARY OF SELECTED ABBREVIATED TERMS*
| Abbreviated Term | Defined Term | |||||||
| 1.00% Notes | 1.00% Convertible Senior Notes due 2020 | |||||||
| 1.625% Notes | 1.625% Convertible Senior Notes due 2023 | |||||||
| Amended Credit Agreement | Credit Agreement, dated as of April 15, 2016, as subsequently amended, by and among the Company, as borrower, the several lenders party thereto, Deutsche Bank AG, New York Branch, as administrative agent and collateral agent, and certain other parties, providing for the Revolving Credit Facility and the Term Loan “B” Facility | |||||||
| Amended and Restated SIP | ON Semiconductor Corporation Amended and Restated Stock Incentive Plan, as amended | |||||||
| AMIS | AMIS Holdings, Inc. | |||||||
| Aptina | Aptina, Inc. | |||||||
| ASIC | Application specific integrated circuit | |||||||
| ASU | Accounting Standards Update | |||||||
| BEPS | Base Erosion Profit Shifting, as defined by the OECD | |||||||
| DSP | Digital signal processing | |||||||
| EPA | Environmental Protection Agency | |||||||
| ESPP | ON Semiconductor Corporation 2000 Employee Stock Purchase Plan, as amended | |||||||
| Exchange Act | Securities Exchange Act of 1934, as amended | |||||||
| Fairchild | Fairchild Semiconductor International, Inc. | |||||||
| FASB | Financial Accounting Standards Board | |||||||
| Freescale | Freescale Semiconductor, Inc. | |||||||
| IC | Integrated circuit | |||||||
| IoT | Internet-of-Things | |||||||
| IP | Intellectual property | |||||||
| LED | Light-emitting diode | |||||||
| LIBO Rate | A base rate per annum equal to the London Interbank Offered Rate as administered by the International Exchange Benchmark Administration | |||||||
| LiDAR | Light detection and ranging | |||||||
| MCU | Microcontroller unit | |||||||
| ODM | Original device manufacturers | |||||||
| OECD | Organization for Economic Co-operation and Development | |||||||
| OEM | Original equipment manufacturers | |||||||
| PRP | Potentially Responsible Party | |||||||
| Revolving Credit Facility | A $1.97 billion revolving credit facility created pursuant to the Amended Credit Agreement | |||||||
| RSU | Restricted stock unit | |||||||
| SEC | Securities and Exchange Commission | |||||||
| SoC | System on chip | |||||||
| Securities Act | Securities Act of 1933, as amended | |||||||
| Term Loan “B” Facility | A $2.4 billion term loan “B” facility created pursuant to the Amended Credit Agreement | |||||||
| Wi-Fi | Wireless radio technologies compliant with Institute of Electrical and Electronics Engineers Standard 802.11b and commonly used in wireless local area networking devices | |||||||
| WSTS | World Semiconductor Trade Statistics | |||||||
* Terms used, but not defined, within the body of the Form 10-Q are defined in this Glossary.
PART I: FINANCIAL INFORMATION
Item 1. Financial Statements (unaudited)
ON SEMICONDUCTOR CORPORATION
CONSOLIDATED BALANCE SHEETS
(in millions, except share and per share data)
(unaudited)
| July 3, 2020 | December 31, 2019 | ||||||||||
| Assets | |||||||||||
| Cash and cash equivalents | $ | $ | |||||||||
| Receivables, net | |||||||||||
| Inventories | |||||||||||
| Other current assets | |||||||||||
| Total current assets | |||||||||||
| Property, plant and equipment, net | |||||||||||
| Goodwill | |||||||||||
| Intangible assets, net | |||||||||||
| Deferred tax assets | |||||||||||
| Other assets | |||||||||||
| Total assets | $ | $ | |||||||||
| Liabilities, Non-Controlling Interest and Stockholders’ Equity | |||||||||||
| Accounts payable | $ | $ | |||||||||
| Accrued expenses and other current liabilities | |||||||||||
| Current portion of long-term debt | |||||||||||
| Total current liabilities | |||||||||||
| Long-term debt | |||||||||||
| Deferred tax liabilities | |||||||||||
| Other long-term liabilities | |||||||||||
| Total liabilities | |||||||||||
| Commitments and contingencies (Note 10) | |||||||||||
| ON Semiconductor Corporation stockholders’ equity: | |||||||||||
Common stock ($ | |||||||||||
| Additional paid-in capital | |||||||||||
| Accumulated other comprehensive loss | ( | ( | |||||||||
| Accumulated earnings | |||||||||||
Less: Treasury stock, at cost: | ( | ( | |||||||||
| Total ON Semiconductor Corporation stockholders’ equity | |||||||||||
| Non-controlling interest | |||||||||||
| Total stockholders' equity | |||||||||||
| Total liabilities and stockholders' equity | $ | $ | |||||||||
See accompanying notes to consolidated financial statements
4
ON SEMICONDUCTOR CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
(in millions, except per share data)
(unaudited)
| Quarters Ended | Six Months Ended | ||||||||||||||||||||||||||||||||||
| July 3, 2020 | June 28, 2019 | July 3, 2020 | June 28, 2019 | ||||||||||||||||||||||||||||||||
| Revenue | $ | $ | $ | $ | |||||||||||||||||||||||||||||||
| Cost of revenue (exclusive of amortization shown below) | |||||||||||||||||||||||||||||||||||
| Gross profit | |||||||||||||||||||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||||||||||||||
| Research and development | |||||||||||||||||||||||||||||||||||
| Selling and marketing | |||||||||||||||||||||||||||||||||||
| General and administrative | |||||||||||||||||||||||||||||||||||
| Amortization of acquisition-related intangible assets | |||||||||||||||||||||||||||||||||||
| Restructuring, asset impairments and other charges, net | |||||||||||||||||||||||||||||||||||
| Intangible asset impairment | |||||||||||||||||||||||||||||||||||
| Total operating expenses | |||||||||||||||||||||||||||||||||||
| Operating income | |||||||||||||||||||||||||||||||||||
| Other income (expense), net: | |||||||||||||||||||||||||||||||||||
| Interest expense | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
| Interest income | |||||||||||||||||||||||||||||||||||
| Loss on debt refinancing and prepayment | ( | ( | |||||||||||||||||||||||||||||||||
| Other income (expense) | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Other income (expense), net | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
| Income (loss) before income taxes | ( | ( | |||||||||||||||||||||||||||||||||
| Income tax (provision) benefit | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Net income (loss) | ( | ( | |||||||||||||||||||||||||||||||||
| Less: Net income attributable to non-controlling interest | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
| Net income (loss) attributable to ON Semiconductor Corporation | $ | ( | $ | $ | ( | $ | |||||||||||||||||||||||||||||
| Comprehensive income (loss), net of tax: | |||||||||||||||||||||||||||||||||||
| Net income (loss) | $ | ( | $ | $ | ( | $ | |||||||||||||||||||||||||||||
| Foreign currency translation adjustments | ( | ||||||||||||||||||||||||||||||||||
| Effects of cash flow hedges | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
| Other comprehensive loss, net of tax | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
| Comprehensive income (loss) | ( | ( | |||||||||||||||||||||||||||||||||
| Comprehensive income attributable to non-controlling interest | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
| Comprehensive income (loss) attributable to ON Semiconductor Corporation | $ | ( | $ | $ | ( | $ | |||||||||||||||||||||||||||||
| Net income (loss) per share of common stock attributable to ON Semiconductor Corporation: | |||||||||||||||||||||||||||||||||||
| Basic | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||||
| Diluted | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||||
| Weighted-average shares of common stock outstanding: | |||||||||||||||||||||||||||||||||||
| Basic | |||||||||||||||||||||||||||||||||||
| Diluted | |||||||||||||||||||||||||||||||||||
See accompanying notes to consolidated financial statements
5
ON SEMICONDUCTOR CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(in millions, except share data)
(unaudited)
| Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Loss | Treasury Stock | Non-Controlling Interest | |||||||||||||||||||||||||||||||
| Number of shares | At Par Value | Accumulated Earnings | Number of shares | At Cost | Total Equity | ||||||||||||||||||||||||||||||
| Balance at April 3, 2020 | $ | $ | $ | ( | $ | ( | $ | ( | $ | $ | |||||||||||||||||||||||||
| Shares issued pursuant to the ESPP | — | — | — | — | — | — | |||||||||||||||||||||||||||||
| RSUs and stock grant awards issued | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||
| Payment of tax withholding for RSUs | — | — | — | — | — | ( | ( | — | ( | ||||||||||||||||||||||||||
| Share-based compensation expense | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||
| Comprehensive (loss) income | — | — | — | ( | ( | — | — | ( | |||||||||||||||||||||||||||
| Balance at July 3, 2020 | $ | $ | $ | ( | $ | ( | $ | ( | $ | $ | |||||||||||||||||||||||||
| Balance at December 31, 2019 | $ | $ | $ | ( | $ | ( | $ | ( | $ | $ | |||||||||||||||||||||||||
| Shares issued pursuant to the ESPP | — | — | — | — | — | — | |||||||||||||||||||||||||||||
| RSUs and stock grant awards issued | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||
| Payment of tax withholding for RSUs | — | — | — | — | — | ( | ( | — | ( | ||||||||||||||||||||||||||
| Share-based compensation expense | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||
| Repurchase of common stock | — | — | — | — | — | ( | ( | — | ( | ||||||||||||||||||||||||||
| Comprehensive (loss) income | — | — | — | ( | ( | — | — | ( | |||||||||||||||||||||||||||
| Balance at July 3, 2020 | $ | $ | $ | ( | $ | ( | $ | ( | $ | $ | |||||||||||||||||||||||||
| Balance at March 29, 2019 | $ | $ | $ | ( | $ | ( | $ | ( | $ | $ | |||||||||||||||||||
| Stock option exercises | — | — | — | — | — | — | |||||||||||||||||||||||
| Shares issued pursuant to the ESPP | — | — | — | — | — | — | |||||||||||||||||||||||
| RSUs and stock grant awards issued | — | — | — | — | — | — | |||||||||||||||||||||||
| Payment of tax withholding for RSUs | — | — | — | — | — | ( | ( | — | ( | ||||||||||||||||||||
| Share-based compensation expense | — | — | — | — | — | — | — | ||||||||||||||||||||||
| Repurchase of common stock | — | — | — | — | — | ( | ( | — | ( | ||||||||||||||||||||
| Comprehensive (loss) income | — | — | — | ( | — | — | |||||||||||||||||||||||
| Balance at June 28, 2019 | $ | $ | $ | ( | $ | ( | $ | ( | $ | $ | |||||||||||||||||||
| Balance at December 31, 2018 | $ | $ | $ | ( | $ | ( | $ | ( | $ | $ | |||||||||||||||||||
| Stock option exercises | — | — | — | — | — | — | |||||||||||||||||||||||
| Shares issued pursuant to the ESPP | — | — | — | — | — | — | |||||||||||||||||||||||
| RSUs and stock grant awards issued | — | — | — | — | — | — | |||||||||||||||||||||||
| Payment of tax withholding for RSUs | — | — | — | — | — | ( | ( | — | ( | ||||||||||||||||||||
| Share-based compensation expense | — | — | — | — | — | — | — | ||||||||||||||||||||||
| Repurchase of common stock | — | — | — | — | — | ( | ( | — | ( | ||||||||||||||||||||
| Comprehensive (loss) income | — | — | — | ( | — | — | |||||||||||||||||||||||
| Balance at June 28, 2019 | $ | $ | $ | ( | $ | ( | $ | ( | $ | $ | |||||||||||||||||||
See accompanying notes to consolidated financial statements
6
ON SEMICONDUCTOR CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
(unaudited)
| Six Months Ended | |||||||||||||||||
| July 3, 2020 | June 28, 2019 | ||||||||||||||||
| Cash flows from operating activities: | |||||||||||||||||
| Net income (loss) | $ | ( | $ | ||||||||||||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||||||||||||||
| Depreciation and amortization | |||||||||||||||||
| Non-cash (gain) loss on sale or disposal of fixed assets | ( | ||||||||||||||||
| Loss on debt refinancing and prepayment | |||||||||||||||||
| Amortization of debt discount and issuance costs | |||||||||||||||||
| Share-based compensation expense | |||||||||||||||||
| Non-cash interest on convertible notes | |||||||||||||||||
| Non-cash asset impairment charges | |||||||||||||||||
| Intangible asset impairment charges | |||||||||||||||||
| Change in deferred tax balances | ( | ||||||||||||||||
| Other | |||||||||||||||||
| Changes in assets and liabilities (exclusive of the impact of acquisitions): | |||||||||||||||||
| Receivables | ( | ||||||||||||||||
| Inventories | ( | ( | |||||||||||||||
| Other assets | ( | ||||||||||||||||
| Accounts payable | ( | ||||||||||||||||
| Accrued expenses and other current liabilities | ( | ( | |||||||||||||||
| Other long-term liabilities | ( | ( | |||||||||||||||
| Net cash provided by operating activities | |||||||||||||||||
| Cash flows from investing activities: | |||||||||||||||||
| Purchase of property, plant and equipment | ( | ( | |||||||||||||||
| Proceeds from sale of property, plant and equipment | |||||||||||||||||
| Deposits utilized (made) for purchase of property, plant and equipment | ( | ||||||||||||||||
| Purchase of business, net of cash acquired | ( | ( | |||||||||||||||
| Purchase of license and deposit made for manufacturing facility | ( | ||||||||||||||||
| Release of escrow related to divestiture | |||||||||||||||||
| Settlement of purchase price from previous acquisition | |||||||||||||||||
| Net cash used in investing activities | ( | ( | |||||||||||||||
| Cash flows from financing activities: | |||||||||||||||||
| Proceeds for the issuance of common stock under the ESPP | |||||||||||||||||
| Proceeds from exercise of stock options | |||||||||||||||||
| Payment of tax withholding for RSUs | ( | ( | |||||||||||||||
| Repurchase of common stock | ( | ( | |||||||||||||||
| Borrowings under debt agreements | |||||||||||||||||
| Payment of debt issuance and other financing costs | ( | ||||||||||||||||
| Repayment of long-term debt | ( | ( | |||||||||||||||
| Acquisition related payments | ( | ||||||||||||||||
| Payment of finance lease obligations | ( | ||||||||||||||||
| Net cash provided by financing activities | |||||||||||||||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||||||||||||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | ( | ||||||||||||||||
| Cash, cash equivalents and restricted cash, beginning of period (Note 6) | |||||||||||||||||
| Cash, cash equivalents and restricted cash, end of period (Note 6) | $ | $ | |||||||||||||||
See accompanying notes to consolidated financial statements
7
ON SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
Note 1: Background and Basis of Presentation
ON Semiconductor Corporation, together with its wholly and majority-owned subsidiaries ("ON Semiconductor," "we," “us,” “our,” or the "Company"), uses a thirteen-week fiscal quarter accounting period for the first three fiscal quarters of each year, with the second quarter of 2020 having ended on July 3, 2020 and each fiscal year ending on December 31. The quarters ended July 3, 2020 and June 28, 2019 each contained 91 185 and 179 days, respectively. As of July 3, 2020, the Company was organized into the following three
The accompanying unaudited financial statements as of and for the quarter and six months ended July 3, 2020 have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for unaudited interim financial information. Accordingly, the unaudited financial statements do not include all of the information and footnotes required by GAAP for audited financial statements. The balance sheet as of December 31, 2019 was derived from the Company's audited financial statements but does not include all disclosures required by GAAP for audited financial statements. In the opinion of the Company's management, the interim information includes all adjustments, which includes normal recurring adjustments, necessary for a fair statement of the results for the interim periods. The footnote disclosures related to the interim financial information included herein are also unaudited. Such financial information should be read in conjunction with the consolidated financial statements and related notes thereto for the year ended December 31, 2019 included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2019, which was filed with the SEC on February 19, 2020 (the “2019 Form 10-K”).
Use of Estimates
The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amount of revenue and expenses during the reporting period. Management evaluates these estimates and judgments on an ongoing basis and bases its estimates on experience, current and expected future conditions, third-party evaluations and various other assumptions that management believes are reasonable under the circumstances. Significant estimates have been used by management in conjunction with the following: (i) future payouts for customer incentives and amounts subject to allowances and returns; (ii) valuation and obsolescence relating to inventories; (iii) fair values of share-based compensation; and (iv) measurement of valuation allowances against deferred tax assets and evaluations of unrecognized tax benefits. Even though the novel coronavirus disease 2019 (“COVID-19”) pandemic impacted the demand for the Company's products and gross margin, it did not have a significant impact on these estimates. Additionally, during periods where it becomes applicable, significant estimates will be used by management in determining the future cash flows used to assess and test for impairment of indefinite-lived intangible assets, long-lived assets and goodwill and in assumptions used in connection with business combinations. Actual results may differ from the estimates and assumptions used in the consolidated financial statements.
The Company assessed certain accounting matters that generally require consideration of forecasted financial information in the context of the information reasonably available and the unknown future impact of the COVID-19 pandemic as of July 3, 2020, and through the date of this Form 10-Q. The accounting matters assessed included, but were not limited to, the allowance for doubtful accounts, share based compensation, inventory valuation and corresponding reserves, carrying value of indefinite-lived assets, other long-lived assets and goodwill, valuation allowance for tax assets, contingencies and revenue recognition. While there was not a material impact to the consolidated financial statements as of and for the quarter and six months ended July 3, 2020, resulting from these assessments, future assessment of the current expectations, including of the magnitude and duration of the COVID-19 pandemic, as well as other factors, could result in a material adverse impact to the consolidated financial statements in future reporting periods.
8
ON SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued
(unaudited)
Note 2: Revenue and Segment Information
The Company is organized into three
Revenue and gross profit for the Company’s operating and reportable segments are as follows (in millions):
| PSG | ASG | ISG | Total | ||||||||||||||||||||
| For the quarter ended July 3, 2020: | |||||||||||||||||||||||
| Revenue from external customers | $ | $ | $ | $ | |||||||||||||||||||
| Gross profit | $ | $ | $ | $ | |||||||||||||||||||
| For the quarter ended June 28, 2019: | |||||||||||||||||||||||
| Revenue from external customers | $ | $ | $ | $ | |||||||||||||||||||
| Gross profit | $ | $ | $ | $ | |||||||||||||||||||
| For the six months ended July 3, 2020: | |||||||||||||||||||||||
| Revenue from external customers | $ | $ | $ | $ | |||||||||||||||||||
| Gross profit | $ | $ | $ | $ | |||||||||||||||||||
| For the six months ended June 28, 2019: | |||||||||||||||||||||||
| Revenue from external customers | $ | $ | $ | $ | |||||||||||||||||||
| Gross profit | $ | $ | $ | $ | |||||||||||||||||||
The Company had one customer, a distributor, whose revenue accounted for approximately 11 % and 10 % of the total revenue for the quarter and six months ended July 3, 2020, respectively.
Gross profit is exclusive of the amortization of acquisition-related intangible assets. Depreciation expense is included in segment gross profit. Reconciliation of segment gross profit to consolidated gross profit is provided below (in millions):
| Quarters Ended | Six Months Ended | ||||||||||||||||||||||||||||||||||
| July 3, 2020 | June 28, 2019 | July 3, 2020 | June 28, 2019 | ||||||||||||||||||||||||||||||||
| Gross profit for reportable segments | $ | $ | $ | $ | |||||||||||||||||||||||||||||||
| Less: Unallocated manufacturing costs | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
| Consolidated gross profit | $ | $ | $ | $ | |||||||||||||||||||||||||||||||
9
ON SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued
(unaudited)
Revenue for the Company's operating and reportable segments disaggregated into geographic locations based on sales billed from the respective country and sales channels are as follows (in millions):
| Quarter Ended July 3, 2020 | |||||||||||||||||||||||||||||||||||||||||
| PSG | ASG | ISG | Total | ||||||||||||||||||||||||||||||||||||||
| Geographic Location | |||||||||||||||||||||||||||||||||||||||||
| Singapore | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
| Hong Kong | |||||||||||||||||||||||||||||||||||||||||
| United Kingdom | |||||||||||||||||||||||||||||||||||||||||
| United States | |||||||||||||||||||||||||||||||||||||||||
| Other | |||||||||||||||||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
| Sales Channel | |||||||||||||||||||||||||||||||||||||||||
| Distributors | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
| OEM/ODM | |||||||||||||||||||||||||||||||||||||||||
| Electronic Manufacturing Service Providers | |||||||||||||||||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
| Six Months Ended July 3, 2020 | |||||||||||||||||||||||||||||||||||||||||
| PSG | ASG | ISG | Total | ||||||||||||||||||||||||||||||||||||||
| Geographic Location | |||||||||||||||||||||||||||||||||||||||||
| Singapore | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
| Hong Kong | |||||||||||||||||||||||||||||||||||||||||
| United Kingdom | |||||||||||||||||||||||||||||||||||||||||
| United States | |||||||||||||||||||||||||||||||||||||||||
| Other | |||||||||||||||||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
| Sales Channel | |||||||||||||||||||||||||||||||||||||||||
| Distributors | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
| OEM/ODM | |||||||||||||||||||||||||||||||||||||||||
| Electronic Manufacturing Service Providers | |||||||||||||||||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
10
ON SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued
(unaudited)
| Quarter Ended June 28, 2019 | |||||||||||||||||||||||||||||||||||||||||
| PSG | ASG | ISG | Total | ||||||||||||||||||||||||||||||||||||||
| Geographic Location | |||||||||||||||||||||||||||||||||||||||||
| Singapore | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
| Hong Kong | |||||||||||||||||||||||||||||||||||||||||
| United Kingdom | |||||||||||||||||||||||||||||||||||||||||
| United States | |||||||||||||||||||||||||||||||||||||||||
| Other | |||||||||||||||||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
| Sales Channel | |||||||||||||||||||||||||||||||||||||||||
| Distributors | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
| OEM/ODM | |||||||||||||||||||||||||||||||||||||||||
| Electronic Manufacturing Service Providers | |||||||||||||||||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
| Six Months Ended June 28, 2019 | |||||||||||||||||||||||||||||||||||||||||
| PSG | ASG | ISG | Total | ||||||||||||||||||||||||||||||||||||||
| Geographic Location | |||||||||||||||||||||||||||||||||||||||||
| Singapore | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
| Hong Kong | |||||||||||||||||||||||||||||||||||||||||
| United Kingdom | |||||||||||||||||||||||||||||||||||||||||
| United States | |||||||||||||||||||||||||||||||||||||||||
| Other | |||||||||||||||||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
| Sales Channel | |||||||||||||||||||||||||||||||||||||||||
| Distributors | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
| OEM/ODM | |||||||||||||||||||||||||||||||||||||||||
| Electronic Manufacturing Service Providers | |||||||||||||||||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
The Company operates in various geographic locations. Sales to unaffiliated customers have little correlation with the location of manufacturers. It is, therefore, not meaningful to present operating profit by geographical location.
The Company does not discretely allocate assets to its operating segments, nor does management evaluate operating segments using discrete asset information. The Company’s consolidated assets are not specifically ascribed to its individual reportable segments. Rather, assets used in operations are generally shared across the Company’s operating and reportable segments.
11
ON SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued
(unaudited)
Property, plant and equipment, net by geographic location, is summarized as follows (in millions):
| As of | |||||||||||||||||
| July 3, 2020 | December 31, 2019 | ||||||||||||||||
| United States | $ | $ | |||||||||||||||
| South Korea | |||||||||||||||||
| Philippines | |||||||||||||||||
| China | |||||||||||||||||
| Japan | |||||||||||||||||
| Czech Republic | |||||||||||||||||
| Malaysia | |||||||||||||||||
| Other | |||||||||||||||||
| Total | $ | $ | |||||||||||||||
Note 3: Recent Accounting Pronouncements
Adopted:
ASU 2020-04 – Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”)
In March 2020, the FASB issued ASU 2020-04 to address constituents’ concerns about certain accounting consequences that could result from the global markets’ anticipated transition away from the use of the LIBO Rate and other interbank offered rates to alternative reference rates. ASU 2020-04 includes optional expedients and the relief provided is elective and applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference LIBO Rate or another reference rate expected to be discontinued because of reference rate reform. These amendments are effective for entities as of March 12, 2020 through December 31, 2022. The Company elected to apply the provisions of ASU 2020-04 for its contracts and hedging relationships as of March 12, 2020. The adoption of ASU 2020-04 did not have a material impact on its consolidated financial statements.
ASU 2019-12 – Income taxes (Topic 740): Simplifying the accounting for income taxes (“ASU 2019-12”)
In December 2019, the FASB issued ASU 2019-12 which simplifies the accounting for income taxes by removing certain exceptions to the general principles in Income taxes (Topic 740). The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company early adopted ASU 2019-12 during the quarter ended April 3, 2020. The adoption of ASU 2019-12 did not have a material impact on its consolidated financial statements.
12
ON SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued
(unaudited)
Pending adoption:
ASU 2020-06 - Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”)
Note 4: Acquisitions
Acquisition of Quantenna
On June 19, 2019, the Company acquired 100 % of the outstanding shares of Quantenna Communications, Inc. ("Quantenna"), a global leader and innovator of high performance Wi-Fi solutions, whereby Quantenna became a wholly-owned subsidiary of the Company. The purchase price consideration for the acquisition totaled $1,039.3 million.
Pro-Forma Results of Operations
The following unaudited pro-forma consolidated results of operation for the quarters and six months ended July 3, 2020 and June 28, 2019 have been prepared as if the acquisition of Quantenna had occurred on January 1, 2018 and includes adjustments for amortization of intangibles, interest expense from financing, restructuring, and the effect of purchase accounting adjustments including the step-up of inventory (in millions):
| Quarters Ended | Six Months Ended | ||||||||||||||||||||||
| July 3, 2020 | June 28, 2019 | July 3, 2020 | June 28, 2019 | ||||||||||||||||||||
| Revenue | $ | $ | $ | $ | |||||||||||||||||||
| Net income (loss) | ( | ( | |||||||||||||||||||||
| Net income (loss) attributable to ON Semiconductor Corporation | ( | ( | |||||||||||||||||||||
| Net income (loss) per share of common stock attributable to ON Semiconductor Corporation: | |||||||||||||||||||||||
| Basic | $ | $ | $ | ( | $ | ||||||||||||||||||
| Diluted | $ | $ | $ | ( | $ | ||||||||||||||||||
Note 5: Restructuring, Asset Impairments and Other, Net
13
ON SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued
(unaudited)
| Restructuring | Asset Impairments (1) | Other | Total | ||||||||||||||||||||||||||||||||||||||
| Quarter ended July 3, 2020 | |||||||||||||||||||||||||||||||||||||||||
| 2020 Involuntary separation program | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
| Other | ( | ||||||||||||||||||||||||||||||||||||||||
| Total | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||||||||||
| Restructuring | Asset Impairments (1) | Other | Total | ||||||||||||||||||||||||||||||||||||||
| Six months ended July 3, 2020 | |||||||||||||||||||||||||||||||||||||||||
| Voluntary separation program | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
| 2020 Involuntary separation program | |||||||||||||||||||||||||||||||||||||||||
| Other general workforce reduction | |||||||||||||||||||||||||||||||||||||||||
| Other | ( | ||||||||||||||||||||||||||||||||||||||||
| Total | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||||||||||
Summary of changes in accrued restructuring from December 31, 2019 to July 3, 2020 is as follows (in millions):
| As of | As of | |||||||||||||||||||||||||||||||
| December 31, 2019 | Charges | Usage | July 3, 2020 | |||||||||||||||||||||||||||||
| Employee separation charges | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||
| Other | ( | |||||||||||||||||||||||||||||||
| Total | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||
Voluntary Separation Program
During the first quarter of 2020, the Company offered a voluntary separation program (the "VSP") to employees that met certain criteria. Participation was subject to management review and approval. The purpose of the VSP was to allow employees to voluntarily separate employment during a specific time and with enhanced separation compensation and benefits, thereby enabling the Company to optimize its cost structure and progress towards its target financial model. Management approved 243 employees for participation in the VSP during the quarter ended April 3, 2020, after which the VSP was terminated. During the quarter ended April 3, 2020, the aggregate expense for the VSP amounted to $27.5 million for the 243 employees, all of whom had exited the Company as of July 3, 2020. During the quarter ended July 3, 2020, the Company paid $20.4 million of the aggregate expense and had $7.1 million accrued as of July 3, 2020, which is expected to be paid during the third quarter of 2020.
2020 Involuntary Separation Program
During the second quarter of 2020, the Company implemented an involuntary separation program (the “ISP”) . Under the ISP, the Company notified approximately 191 employees of their employment termination with aggregate severance costs and other benefits amounting to $11.8 million, of which $6.8 million remained accrued as of July 3, 2020. This amount is expected to be paid during the third and fourth quarters of 2020 depending on the exit date of the notified employees. The Company currently does not anticipate additional employee terminations under the ISP.
Other General Workforce Reduction
In addition to the VSP and the ISP, the Company took other general workforce reduction measures (including the post-Quantenna acquisition restructuring) during the first quarter of 2020. In connection with such measures, the Company notified approximately 98 employees of their employment termination, all of whom exited by April 3, 2020. During the quarter ended April 3, 2020, the aggregate expense for these other general workforce reduction measures amounted to $3.8 million and were paid out within the quarter. There was no activity under this program during the second quarter of 2020. The Company
14
ON SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued
(unaudited)
Note 6: Balance Sheet Information and Other
Goodwill
Changes in the goodwill balance from December 31, 2019 through July 3, 2020 were as follows (in millions):
| Net balance as of December 31, 2019 | $ | |||||||
| Addition due to business combination | ||||||||
| Net balance as of July 3, 2020 | $ | |||||||
Goodwill is tested for impairment annually on the first day of the fourth quarter or more frequently if events or changes in circumstances (each, a "triggering event") would more likely than not reduce the carrying value of goodwill below its fair value. Management considered the general economic decline and the impact of the COVID-19 pandemic, but did not identify any triggering events during the quarter and six months ended July 3, 2020 that would require an interim impairment analysis.
Inventory
Details of Inventory included in the Company’s Consolidated Balance Sheets are as follows (in millions):
| As of | |||||||||||||||||
| July 3, 2020 | December 31, 2019 | ||||||||||||||||
| Inventories: | |||||||||||||||||
| Raw materials | $ | $ | |||||||||||||||
| Work in process | |||||||||||||||||
| Finished goods | |||||||||||||||||
| $ | $ | ||||||||||||||||
Defined Benefit Plans
As of July 3, 2020, the total accrued pension liability for underfunded plans was $133.5 million, of which the current portion of $0.3 million was classified as accrued expenses and other current liabilities. As of December 31, 2019, the total accrued pension liability for underfunded plans was $132.7 million, of which the current portion of $0.3 million was classified as accrued expenses and other current liabilities.
The components of the net periodic pension expense were as follows (in millions):
| Quarters Ended | Six Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| July 3, 2020 | June 28, 2019 | July 3, 2020 | June 28, 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Service cost | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest cost | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Expected return on plan assets | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Curtailment gain | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total net periodic pension cost | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases
Operating lease arrangements are comprised primarily of real estate and equipment agreements. The components of lease expense were as follows (in millions):
15
ON SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued
(unaudited)
| Quarters Ended | Six Months Ended | |||||||||||||||||||||||||||||||||||||
| July 3, 2020 | June 28, 2019 | July 3, 2020 | June 28, 2019 | |||||||||||||||||||||||||||||||||||
| Operating lease | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
| Variable lease | ||||||||||||||||||||||||||||||||||||||
| Short-term lease | ||||||||||||||||||||||||||||||||||||||
| Total lease expense | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
The lease liabilities recognized in the Consolidated Balance Sheets are as follows (in millions):
| As of | |||||||||||||||||
| July 3, 2020 | December 31, 2019 | ||||||||||||||||
| Accrued expenses and other current liabilities | $ | $ | |||||||||||||||
| Other long-term liabilities | |||||||||||||||||
| Total lease obligations | $ | $ | |||||||||||||||
Operating lease assets of $143.4 million and $110.2 million are included in other assets in the Consolidated Balance Sheets as of July 3, 2020 and December 31, 2019, respectively. As of July 3, 2020, the weighted-average remaining lease-term was 7.2 years and the weighted-average discount rate was 5.0 %.
Supplemental Disclosure of Cash Flow Information
Certain of the Company's cash and non-cash activities were as follows (in millions):
| Six Months Ended | |||||||||||||||||||||||||||||
| July 3, 2020 | June 28, 2019 | ||||||||||||||||||||||||||||
| Non-cash investing activities: | |||||||||||||||||||||||||||||
| Capital expenditures in accounts payable and other long-term liabilities | $ | $ | |||||||||||||||||||||||||||
| Sale of property in exchange of note receivable | $ | ||||||||||||||||||||||||||||
| Right-of-use assets obtained in exchange of lease liabilities | |||||||||||||||||||||||||||||
| Non-cash financing activity: | |||||||||||||||||||||||||||||
| Liability incurred for purchase of business | $ | $ | |||||||||||||||||||||||||||
| Cash (received) paid for: | |||||||||||||||||||||||||||||
| Interest income | $ | ( | $ | ( | |||||||||||||||||||||||||
| Interest expense | |||||||||||||||||||||||||||||
| Income taxes | |||||||||||||||||||||||||||||
| Operating lease payments in operating cash flows | |||||||||||||||||||||||||||||
Reconciliation of the captions in the Consolidated Balance Sheets to the Consolidated Statements of Cash Flows (in millions):
| As of | ||||||||||||||||||||||||||||||||||||||||||||
| July 3, 2020 | December 31, 2019 | June 28, 2019 | December 31, 2018 | |||||||||||||||||||||||||||||||||||||||||
| Consolidated Balance Sheets: | ||||||||||||||||||||||||||||||||||||||||||||
| Cash and cash equivalents | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||
| Restricted cash (included in other current assets) | ||||||||||||||||||||||||||||||||||||||||||||
| Cash, cash equivalents and restricted cash in Consolidated Statements of Cash Flows | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||
16
ON SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued
(unaudited)
Note 7: Long-Term Debt
The Company's long-term debt consists of the following (annualized interest rates, in millions):
| As of | |||||||||||||||||
| July 3, 2020 | December 31, 2019 | ||||||||||||||||
| Amended Credit Agreement: | |||||||||||||||||
Revolving Credit Facility due 2024, interest payable monthly at | $ | $ | |||||||||||||||
Term Loan “B” Facility due 2026, interest payable monthly at | |||||||||||||||||
| Other long-term debt (3) | |||||||||||||||||
| Gross long-term debt, including current portion | $ | $ | |||||||||||||||
| Less: Debt discount (4) | ( | ( | |||||||||||||||
| Less: Debt issuance costs (5) | ( | ( | |||||||||||||||
| Net long-term debt, including current portion | $ | $ | |||||||||||||||
| Less: Current portion of long-term debt | ( | ( | |||||||||||||||
| Net long-term debt | $ | $ | |||||||||||||||
(1) Interest is payable on June 1 and December 1 of each year at 1.00 % annually.
(2) Interest is payable on April 15 and October 15 of each year at 1.625 % annually.
(3) Consists of a term loan, finance lease and other facility at certain international locations where interest is payable monthly or quarterly, with interest rates ranging between 1.00 % and 1.48 % and maturity dates in 2020.
(4) Debt discount of $9.6 million and $20.4 million for the 1.00 % Notes, $63.3 million and $71.8 million for the 1.625 % Notes and $9.8 million and $10.5 million for the Term Loan "B" Facility, in each case as of July 3, 2020 and December 31, 2019, respectively.
(5) Debt issuance costs of $1.3 million and $2.8 million for the 1.00 % Notes, $6.1 million and $6.9 million for the 1.625 % Notes and $22.7 million and $24.3 million for the Term Loan "B" Facility, in each case as of July 3, 2020 and December 31, 2019, respectively.
Expected maturities of gross long-term debt (including current portion) as of July 3, 2020 are as follows (in millions):
| Period | Expected Maturities | |||||||
| Remainder of 2020 | $ | |||||||
| 2021 | ||||||||
| 2022 | ||||||||
| 2023 | ||||||||
| 2024 | ||||||||
| Thereafter | ||||||||
| Total | $ | |||||||
The Company was in compliance with its covenants under all debt agreements as of July 3, 2020.
17
ON SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued
(unaudited)
Eighth Amendment to the Amended Credit Agreement
On June 23, 2020, the Company entered into the Eighth Amendment ("Eighth Amendment") to the Amended Credit Agreement with the subsidiary guarantors party thereto, Deutsche Bank AG New York Branch, as administrative agent and collateral agent, and certain Lenders party thereto constituting the Required Lenders (as defined in the Amended Credit Agreement). The Eighth Amendment provided for, among other things, (i) replace the defined term “Capital Lease Obligations” with a new defined term “Finance Lease Obligations” providing that such obligations only include property classified as finance leases under U.S. GAAP and (ii) make certain amendments in connection with the proposed domestication of ON Management Ltd. and Quantenna Ltd., each of which is a subsidiary of the Company that is not a Loan Party (as defined in the Amended Credit Agreement) and both of which hold economic rights in certain intellectual property, from Bermuda entities to Delaware entities, including, among other things, (a) to permit Investments (as defined in the Amended Credit Agreement) by any Loan Party in any Foreign Subsidiary (as defined in the Amended Credit Agreement) if the proceeds of such Investments are used for Capital Expenditures (as defined in the Amended Credit Agreement) (“Capital Expenditure Investments”) and (b) to increase the amount of certain permitted intercompany Investments by any Loan Party in any subsidiary that is not a Loan Party by an amount (which shall not be less than zero) equal to (A) Net Royalties (as defined in the Amended Credit Agreement) minus (B) the aggregate amount of Capital Expenditure Investments. See Note 15: ''Subsequent Event'' for more information on the domestication of certain foreign subsidiaries, which was completed on July 6, 2020.
Credit Facility Draw
On March 24, 2020, the Company borrowed $1,165.0 million under the Revolving Credit Facility as a precautionary measure in order to increase the Company’s cash position and provide financial flexibility in light of the uncertainty resulting from the impact of the COVID-19 pandemic (the “Credit Facility Draw”). As a result of the Credit Facility Draw, as of July 3, 2020, the Company had borrowed substantially all amounts available under the Revolving Credit Facility and has $4.0 million available for draw under the Revolving Credit Facility, subject to certain conditions. The proceeds from the Credit Facility Draw could be used to repay a portion of debt maturing in 2020, and for working capital, general corporate or other purposes.
Note 8: Earnings Per Share and Equity
Earnings Per Share
Net income (loss) per share of common stock attributable to ON Semiconductor Corporation is calculated as follows (in millions, except per share data):
| Quarters Ended | Six Months Ended | ||||||||||||||||||||||||||||||||||
| July 3, 2020 | June 28, 2019 | July 3, 2020 | June 28, 2019 | ||||||||||||||||||||||||||||||||
| Net income (loss) attributable to ON Semiconductor Corporation | $ | ( | $ | $ | ( | $ | |||||||||||||||||||||||||||||
| Basic weighted-average shares of common stock outstanding | |||||||||||||||||||||||||||||||||||
| Dilutive effect of share-based awards | |||||||||||||||||||||||||||||||||||
| Dilutive effect of convertible notes | |||||||||||||||||||||||||||||||||||
| Diluted weighted-average shares of common stock outstanding | |||||||||||||||||||||||||||||||||||
| Net income (loss) per share of common stock attributable to ON Semiconductor Corporation: | |||||||||||||||||||||||||||||||||||
| Basic | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||||
| Diluted | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||||
Basic income (loss) per share of common stock is computed by dividing net income (loss) attributable to the Company by the weighted average number of shares of common stock outstanding during the period.
To calculate the diluted weighted-average shares of common stock outstanding, the number of incremental shares from the assumed exercise of stock options and assumed issuance of shares relating to RSUs is calculated by applying the treasury stock
18
ON SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued
(unaudited)
method. Share-based awards whose impact is considered to be anti-dilutive under the treasury stock method were excluded from the diluted net income per share calculation. The excluded number of anti-dilutive share-based awards was 3.6 million and 0.6 million for the quarters ended July 3, 2020 and June 28, 2019, respectively, and 3.1 million and 0.6 million for the six months ended July 3, 2020 and June 28, 2019, respectively. The increase in the anti-dilutive share-based awards was due to the net loss for the quarter and six months ended July 3, 2020, as the inclusion would have the effect of decreasing the diluted net loss per share of common stock attributable to the Company.
The dilutive impact related to the 1.00 % Notes and 1.625 % Notes is determined in accordance with the net share settlement requirements, under which the Company's convertible notes are assumed to be convertible into cash up to the par value, with the excess of par value being convertible into common stock. In addition to the net loss for the quarter ended July 3, 2020, the average share price did not exceed the conversion price for both the 1.00 % Notes and 1.625 % Notes, and as a result, was not included in calculating the diluted weighted-average shares of common stock outstanding.
Equity
Share Repurchase Program
Under the Company's share repurchase program announced on November 15, 2018 (the “Share Repurchase Program”), the Company may repurchase up to $1.5 billion (exclusive of fees, commissions and other expenses) of the Company’s common stock from December 1, 2018 through December 31, 2022.
There were no repurchases and $50.0 million in repurchases of the Company's common stock under the Share Repurchase Program during the quarters ended July 3, 2020 and June 28, 2019, respectively. There were $65.3 million and $125.7 million in repurchases of the Company's common stock under the Share Repurchase Program during the six months ended July 3, 2020 and June 28, 2019, respectively. As of July 3, 2020, the authorized amount remaining under the Share Repurchase Program was $1,295.8 million.
Activity under the Share Repurchase Program during the quarter and six months ended July 3, 2020 and June 28, 2019 were as follows (in millions, except per share data):
| Quarters Ended | Six Months Ended | ||||||||||||||||||||||||||||||||||
| July 3, 2020 | June 28, 2019 | July 3, 2020 | June 28, 2019 | ||||||||||||||||||||||||||||||||
| Number of repurchased shares (1) | |||||||||||||||||||||||||||||||||||
| Aggregate purchase price | $ | $ | $ | $ | |||||||||||||||||||||||||||||||
| Fees, commissions and other expenses | |||||||||||||||||||||||||||||||||||
| Total cash used for share repurchases | $ | $ | $ | $ | |||||||||||||||||||||||||||||||
| Weighted-average purchase price per share (2) | $ | $ | $ | $ | |||||||||||||||||||||||||||||||
(1) None of these shares had been reissued or retired as of July 3, 2020, but may be reissued or retired at a later date.
(2) Exclusive of fees, commissions and other expenses.
Shares for Restricted Stock Units Tax Withholding
Shares with a fair market value equal to the applicable amount of the employee withholding taxes due are withheld by the Company upon the vesting of RSUs to pay the applicable amount of employee withholding taxes and are considered common stock repurchases. The Company then pays the applicable amount of withholding taxes in cash. The amounts remitted during the quarters and six months ended July 3, 2020 were $0.6 million and $16.6 million, respectively, for which the Company withheld less than 0.1 million and approximately 0.9 million shares of common stock, respectively, that were underlying the RSUs that vested. The amounts remitted during the quarters and six months ended June 28, 2019 were $1.1 million and $27.2 million, respectively, for which the Company withheld approximately 0.1 million and 1.3 million shares of common stock, respectively, that were underlying the RSUs that vested. Treasury stock is recorded at cost and is presented as a reduction of stockholders' equity in the accompanying consolidated financial statements. None of these shares had been reissued or retired as of July 3, 2020, but may be reissued or retired by the Company at a later date. These repurchases in connection with tax
19
ON SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued
(unaudited)
withholding upon vesting were not made under the Share Repurchase Program, and the amounts spent in connection with such deemed repurchases did not reduce the authorized amount remaining under the Share Repurchase Program.
Non-Controlling Interest
The Company owns 80 % of the outstanding equity interests in a joint venture, Leshan-Phoenix Semiconductor Company Limited (“Leshan”), which operates assembly and test operations in Leshan, China. The results of Leshan have been consolidated in the Company's financial statements. As of December 31, 2019, the non-controlling interest balance was $22.4 million. This balance increased to $23.2 million as of July 3, 2020, resulting from the non-controlling interest’s $0.8 million share of the earnings for the six months ended July 3, 2020.
During the quarter ended April 3, 2020, the Company acquired the remaining 40 % of the equity interest in ON Semiconductor Aizu Co., Ltd., ("OSA") from Fujitsu Semiconductor Limited (“FSL”), whereby OSA became a wholly-owned subsidiary of the Company. OSA operates a front-end wafer fabrication facility in Aizuwakamatsu, Japan. The purchase price payable to FSL for the remaining 40 % equity, offset by the purchase price adjustment, resulted in the Company receiving $26.0 million settlement of purchase price from FSL during the quarter ended April 3, 2020. The results of OSA have been consolidated in the Company’s financial statements since the fourth quarter of 2018, when the Company acquired the majority equity interest.
Stockholders' Rights Plan
On June 7, 2020, the Company's Board of Directors authorized and declared a dividend of one preferred share purchase right (a “Right”) to be issued as of 5:00 p.m. New York City time on June 18, 2020, for each outstanding share of common stock to the stockholders of record on that date. In connection with the Rights, the Company and Computershare Trust Company, N.A., as rights agent, entered into a Rights Agreement, dated as of June 8, 2020 (the “Rights Agreement”). Each Right entitles the registered holder of common stock to purchase from the Company one-hundred-thousandth of a share (a “Unit”) of Series B Junior Participating Preferred Stock, par value $0.01 per share, at a purchase price of $100.80 per Unit (the “Purchase Price”), subject to adjustment as provided in the Rights Agreement. Subject to certain exceptions, if a person or group becomes the beneficial owner of more than 15 % of the Company’s outstanding shares of common stock, the Rights will become exercisable for that number of shares of Common Stock having a market value of two times the Purchase Price. The Rights, which have a de minimis value as of July 3, 2020, expire on the earlier of (i) the close of business on June 7, 2021, (ii) the time at which the Rights are redeemed pursuant to the Rights Agreement, (iii) the closing of any merger or other acquisition transaction involving the Company that has been approved by the Company’s Board of Directors, at which time the Rights are terminated, and (iv) the time at which the Rights are exchanged pursuant to the Rights Agreement. The Rights are in all respects subject to and governed by the provisions of the Rights Agreement.
Note 9: Share-Based Compensation
Total share-based compensation expense related to the Company's RSUs, stock grant awards and the ESPP were recorded within the Consolidated Statements of Operations and Comprehensive Income as follows (in millions):
| Quarters Ended | Six Months Ended | ||||||||||||||||||||||||||||||||||
| July 3, 2020 | June 28, 2019 | July 3, 2020 | June 28, 2019 | ||||||||||||||||||||||||||||||||
| Cost of revenue | $ | $ | $ | $ | |||||||||||||||||||||||||||||||
| Research and development | |||||||||||||||||||||||||||||||||||
| Selling and marketing | |||||||||||||||||||||||||||||||||||
| General and administrative | |||||||||||||||||||||||||||||||||||
| Share-based compensation expense | $ | $ | $ | $ | |||||||||||||||||||||||||||||||
| Income tax benefit | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
| Share-based compensation expense, net of taxes | $ | $ | $ | $ | |||||||||||||||||||||||||||||||
As of July 3, 2020, total unrecognized share-based compensation expense, net of estimated forfeitures, related to non-vested RSUs with service, performance and market conditions was $90.9 million, which is expected to be recognized over a weighted-average period of 1.6 years. There were no 5
20
ON SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued
(unaudited)
Shares Available
As of July 3, 2020 and December 31, 2019, there was an aggregate of 17.3 million and 25.5 million shares of common stock, respectively, available for grant under the Amended and Restated SIP. As of July 3, 2020 and December 31, 2019, there was an aggregate of 3.6 million and 4.8 million shares of common stock, respectively, available for issuance under the ESPP.
Restricted Stock Units
RSUs generally vest ratably over three years for awards with service condition and over two years for awards with performance or market conditions, or a combination thereof, and are settled in shares of the Company's common stock upon vesting. A summary of the RSU transactions for the six months ended July 3, 2020 is as follows (in millions, except per share data):
| Number of Shares | Weighted-Average Grant Date Fair Value Per Share | |||||||||||||
| Non-vested RSUs at December 31, 2019 | $ | |||||||||||||
| Granted | ||||||||||||||
| Released | ( | |||||||||||||
| Forfeited | ( | |||||||||||||
| Non-vested RSUs at July 3, 2020 | ||||||||||||||
Note 10: Commitments and Contingencies
Environmental Contingencies
There are no new environmental contingencies subsequent to the filing of the 2019 Form 10-K.
Financing Contingencies
In the ordinary course of business, the Company provides standby letters of credit or other guarantee instruments to certain parties initiated by either the Company or its subsidiaries, as required for transactions, including, but not limited to, material purchase commitments, agreements to mitigate collection risk, leases, utilities or customs guarantees. As of July 3, 2020, the Company's Revolving Credit Facility included $15.0 million of commitment subject to the available balance of the Revolving Credit Facility for the issuance of letters of credit, which, as of the date of this Form 10-Q was $4.0 million. There were $1.0 million letters of credit outstanding under the Revolving Credit Facility as of July 3, 2020, which reduced the Company's borrowing capacity. As of July 3, 2020, the Company also had outstanding guarantees and letters of credit outside of its Revolving Credit Facility totaling $6.8 million.
As part of obtaining financing in the ordinary course of business, the Company issued guarantees related to certain of its subsidiaries' term loan financing and surety bond, which totaled $1.4 million as of July 3, 2020.
Based on historical experience and information currently available, the Company believes that it will not be required to make payments under the standby letters of credit or guarantee arrangements for the foreseeable future.
Indemnification Contingencies
There are no new indemnification contingencies subsequent to the filing of the 2019 Form 10-K.
Legal Matters
From time to time, the Company is party to various legal proceedings arising in the ordinary course of business, including indemnification claims, claims of alleged infringement of patents, trademarks, copyrights and other IP rights, claims of alleged non-compliance with contract provisions and claims related to alleged violations of laws and regulations. The Company regularly evaluates the status of the legal proceedings in which it is involved to assess whether a loss is probable or there is a reasonable possibility that a loss, or an additional loss, may have been incurred and determines if accruals are appropriate. If
21
ON SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued
(unaudited)
accruals are not appropriate, the Company further evaluates each legal proceeding to assess whether an estimate of possible loss or range of possible loss can be made for disclosure. Although litigation is inherently unpredictable, the Company believes that it has adequate provisions for any probable and estimable losses. Nevertheless, it is possible that the Company’s consolidated financial position, results of operations or liquidity could be materially and adversely affected in any particular period by the resolution of a legal proceeding. The Company’s estimates do not represent its maximum exposure. Legal expenses related to defense, negotiations, settlements, rulings and advice of outside legal counsel are expensed as incurred.
The Company is currently involved in a variety of legal matters that arise in the ordinary course of business. Based on information currently available, except as disclosed below, the Company is not involved in any pending or threatened legal proceedings that it believes could reasonably be expected to have a material adverse effect on its financial condition, results of operations or liquidity. The litigation process is inherently uncertain, and the Company cannot guarantee that the outcome of any litigation matter will be favorable to the Company.
Litigation with AcBel Polytech, Inc.
On November 27, 2013, Fairchild and Fairchild Semiconductor Corporation were named as defendants in a complaint filed by AcBel Polytech, Inc. (“AcBel”) in the U.S. District Court for the District of Massachusetts. The lawsuit alleged a number of causes of action, including breach of warranty, fraud, negligence and strict liability, and has been docketed as AcBel Polytech, Inc. v. Fairchild Semiconductor International, Inc. et al, Case # 1:13-CV-13046-DJC. On December 10, 2016, the Court issued an order on the Company’s motion for summary judgment dismissing all of AcBel’s claims except for claims alleging breach of implied warranties. A bench trial was held in June 2017. On December 27, 2017, the Court rendered a verdict in favor of the Fairchild defendants on the remaining implied warranty claims. AcBel appealed the Court’s ruling, and on September 11, 2018, the U.S. Court of Appeals for the First Circuit heard arguments in this matter from Fairchild and AcBel. On June 20, 2019, the First Circuit vacated the decision of the District Court in favor of Fairchild and remanded the matter for additional discovery and a new trial. The First Circuit also reversed the District Court’s dismissal of the fraud, fraudulent misrepresentation and negligent misrepresentation claims at the summary judgment phase and remanded those claims for trial. The District Court scheduled a new trial for July 6, 2020.
In parallel to the litigation with AcBel, Fairchild filed an arbitration against its distributor, Synnex Technology International Corp (“Synnex”), in Hong Kong in response to Synnex’s failure to pass along Fairchild’s limited warranty to AcBel. The arbitration was held in December 2017. On August 17, 2018, the arbitrator ruled in favor of Fairchild and ordered Synnex to indemnify Fairchild for any damages Fairchild is required to pay AcBel in connection with the litigation between Fairchild and AcBel. On November 16, 2018, Synnex appealed the arbitrator’s ruling. A hearing was held on October 23, 2019, and on November 1, 2019, a Hong Kong court affirmed the arbitrator’s ruling in favor of Fairchild.
Prior to the July 6, 2020 trial, AcBel, Fairchild and Synnex tentatively agreed to a settlement of all disputes related to the litigation. AcBel and Fairchild notified the Court of the potential settlement, and the Court adjourned the case until August 10, 2020. On July 31, 2020, the Company entered into a settlement agreement and release in respect of the dispute with Synnex and Acbel. As of the date of this Form 10-Q, the Company has paid its full aggregate liability of $6.0 million in accordance with the settlement agreement and all applicable claims have been released.
Intellectual Property Matters
The Company faces risk of exposure from claims of infringement of the IP rights of others. In the ordinary course of business, the Company receives letters asserting that the Company’s products or components breach another party’s rights. Such letters may request royalty payments from the Company, that the Company cease and desist using certain IP or other remedies.
22
ON SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued
(unaudited)
Note 11: Fair Value Measurements
Fair Value of Financial Instruments
The following table summarizes the Company's financial assets and liabilities, excluding pension assets, measured at fair value on a recurring basis (in millions):
| As of | Fair Value Hierarchy | |||||||||||||||||||||||||||||||||||||
| Description | July 3, 2020 | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||||||||||||||||
| Assets: | ||||||||||||||||||||||||||||||||||||||
| Cash and cash equivalents: | ||||||||||||||||||||||||||||||||||||||
| Demand and time deposits | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
| As of | Fair Value Hierarchy | |||||||||||||||||||||||||||||||||||||
| Description | December 31, 2019 | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||||||||||||||||
| Assets: | ||||||||||||||||||||||||||||||||||||||
| Cash and cash equivalents: | ||||||||||||||||||||||||||||||||||||||
| Demand and time deposits | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
Other
The carrying amounts of other current assets and liabilities, such as accounts receivable and accounts payable, approximate fair value based on the short-term nature of these instruments.
Fair Value of Long-Term Debt, including Current Portion
The carrying amounts and fair values of the Company’s long-term borrowings (excluding finance lease obligations) are as follows (in millions):
| As of | |||||||||||||||||||||||||||||||||||||||||
| July 3, 2020 | December 31, 2019 | ||||||||||||||||||||||||||||||||||||||||
| Carrying Amount | Fair Value | Carrying Amount | Fair Value | ||||||||||||||||||||||||||||||||||||||
| Long-term debt, including current portion | |||||||||||||||||||||||||||||||||||||||||
| Convertible notes (1) | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
| Long-term debt (1) | |||||||||||||||||||||||||||||||||||||||||
(1) Carrying amount shown is net of debt discount and debt issuance costs.
The fair values of the Company's 1.00 % Notes and 1.625 % Notes were estimated based on market prices in active markets (Level 1). The fair value of other long-term debt was estimated based on discounting the remaining principal and interest payments using current market rates for similar debt (Level 2) at July 3, 2020 and December 31, 2019.
Note 12: Financial Instruments
Foreign Currencies
As a multinational business, the Company’s transactions are denominated in a variety of currencies. When appropriate, the Company uses forward foreign currency contracts to reduce its overall exposure to the effects of currency fluctuations on its results of operations and cash flows. The Company’s policy prohibits trading in currencies for which there are no underlying exposures and entering into trades for any currency to intentionally increase the underlying exposure. The Company primarily hedges existing assets and liabilities associated with transactions currently on its balance sheet, which are undesignated hedges for accounting purposes.
23
ON SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued
(unaudited)
As of July 3, 2020 and December 31, 2019, the Company had net outstanding foreign exchange contracts with notional amounts of $172.5 million and $183.3 million, respectively. Such contracts were obtained through financial institutions and were scheduled to mature within to three months from the time of purchase. Management believes that these financial instruments should not subject the Company to increased risks from foreign exchange movements because gains and losses on these contracts should offset losses and gains on the underlying assets, liabilities and transactions to which they are related.
The following summarizes the Company’s net foreign exchange positions in U.S. Dollars (in millions):
| As of | ||||||||||||||||||||||||||||||||||||||||||||
| July 3, 2020 | December 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||
| Buy (Sell) | Notional Amount | Buy (Sell) | Notional Amount | |||||||||||||||||||||||||||||||||||||||||
| Philippine Peso | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||
| Japanese Yen | ||||||||||||||||||||||||||||||||||||||||||||
| Korean Won | ||||||||||||||||||||||||||||||||||||||||||||
| Euro | ||||||||||||||||||||||||||||||||||||||||||||
| Chinese Yuan | ||||||||||||||||||||||||||||||||||||||||||||
| Malaysian Ringgit | ||||||||||||||||||||||||||||||||||||||||||||
| Czech Koruna | ||||||||||||||||||||||||||||||||||||||||||||
| Other Currencies - Buy | ||||||||||||||||||||||||||||||||||||||||||||
| Other Currencies - Sell | ( | ( | ||||||||||||||||||||||||||||||||||||||||||
| $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||
Amounts receivable or payable under the contracts are included in other current assets or accrued expenses and other current liabilities in the accompanying Consolidated Balance Sheets. During the quarters ended July 3, 2020 and June 28, 2019, realized and unrealized foreign currency transactions totaled a loss of $3.2 million and $1.0 million, respectively. During the six months ended July 3, 2020 and June 28, 2019, realized and unrealized foreign currency transactions totaled a loss of $3.4 million and $4.1 million, respectively. The realized and unrealized foreign currency transactions are included in other income (expense) in the Company's Consolidated Statements of Operations and Comprehensive Income.
Cash Flow Hedges
All derivatives are recognized on the Company’s Consolidated Balance Sheets at their fair value and classified based on the instrument's maturity date.
Interest rate risk
On April 17, 2020, the Company entered into interest rate swap agreements for notional amounts totaling $1.25 billion (effective as of April 30, 2020), $750.0 million (effective as of December 31, 2020) and $750.0 million (effective as of December 31, 2021) with maturity dates of December 31, 2020, December 31, 2021 and December 31, 2022, respectively.
The Company uses interest rate swap contracts to mitigate its exposure to interest rate fluctuations. The Company did not identify any ineffectiveness with respect to the notional amounts of the interest rate swap contracts outstanding as of July 3, 2020 and June 28, 2019, amounting to $2.25 billion and $1.0 billion, respectively.
Foreign currency risk
The purpose of the Company's foreign currency hedging activities is to protect the Company from the risk that the eventual cash flows resulting from transactions in foreign currencies will be adversely affected by changes in exchange rates. The Company enters into forward contracts that are designated as foreign currency cash flow hedges of selected forecasted payments denominated in currencies other than U.S. Dollars.
For the quarters and six months ended July 3, 2020 and June 28, 2019, the Company did not have outstanding derivatives for its foreign currency exposure designated as cash flow hedges.
24
ON SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued
(unaudited)
Convertible Note Hedges
The Company entered into convertible note hedges in connection with the issuance of the 1.00 % Notes and 1.625 % Notes.
Other
At July 3, 2020, the Company had no outstanding commodity derivatives, currency swaps or options relating to either its debt instruments or investments. The Company does not hedge the value of its equity investments in its subsidiaries or affiliated companies. The Company is exposed to credit-related losses if counterparties to hedge contracts fail to perform their obligations. As of July 3, 2020, the counterparties to the Company’s hedge contracts were held at financial institutions that the Company believes to be highly-rated, and no credit-related losses are anticipated.
Note 13: Income Taxes
The Company recognizes interest and penalties related to unrecognized tax benefits in tax expense on the Company's Consolidated Statements of Operations and Comprehensive Income. The Company had approximately $4.6 million and $4.2 million of net interest and penalties accrued at July 3, 2020 and June 28, 2019, respectively. It is reasonably possible that $3.4 million of its unrecognized tax benefits will be reduced in the next 12 months due to settlement with tax authorities or expiration of the applicable statute of limitations.
The Company continues to maintain a full valuation allowance on its U.S. state deferred tax assets and a valuation allowance on foreign net operating losses and tax credits in certain foreign jurisdictions, a substantial portion of which relate to Japan net operating losses, which are projected to expire prior to utilization.
Tax years prior to 2016 are generally not subject to examination by the Internal Revenue Service (the “IRS”) except for items involving tax attributes that have been carried forward to tax years whose statute of limitations remains open. The Company is currently under IRS examination for the 2017 tax year. For state tax returns, the Company is generally not subject to income tax examinations for tax years prior to 2015. The Company is also subject to routine examinations by various foreign tax jurisdictions in which it operates. With respect to jurisdictions outside the United States, the Company is generally not subject to examination for tax years prior to 2009. The Company believes that adequate provisions have been made for any adjustments that may result from tax examinations. However, the outcome of tax audits cannot be predicted with certainty. If any issues addressed in the Company’s tax audits are resolved in a manner not consistent with the Company's expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs.
Note 14: Changes in Accumulated Other Comprehensive Loss
Amounts comprising the Company's accumulated other comprehensive loss and reclassifications are as follows (in millions):
| Currency Translation Adjustments | Effects of Cash Flow Hedges | Total | ||||||||||||||||||||||||
| Balance as of December 31, 2019 | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||
| Other comprehensive income (loss) prior to reclassifications | ( | ( | ||||||||||||||||||||||||
| Amounts reclassified from accumulated other comprehensive loss | ( | ( | ||||||||||||||||||||||||
| Net current period other comprehensive income (loss) (1) | ( | ( | ||||||||||||||||||||||||
| Balance as of July 3, 2020 | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||
(1) Effects of cash flow hedges are net of $3.7 million of tax benefit for the six months ended July 3, 2020.
Amounts reclassified from accumulated other comprehensive loss to the specific caption within Consolidated Statements of Operations and Comprehensive Income were as follows:
25
ON SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued
(unaudited)
| Amounts Reclassified from Accumulated Other Comprehensive Loss | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Quarters Ended | Six Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| July 3, 2020 | June 28, 2019 | July 3, 2020 | June 28, 2019 | To caption | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest rate swaps | $ | $ | ( | $ | $ | ( | Interest expense | |||||||||||||||||||||||||||||||||||||||||||||||||
| Total reclassifications | $ | $ | ( | $ | $ | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||
Note 15: Subsequent Event
On July 6, 2020, the Company completed a simplification of its corporate structure by repatriating the economic rights of its non-U.S. intellectual property to the United States via domestication of certain foreign subsidiaries (the "Domestication"). The Domestication more closely aligns the Company's corporate structure to its operating structure in accordance with the OECD’s BEPS conclusions and changes to U.S. and European tax laws. The impact of the Domestication, which is regarded as a change in tax status, will result in a benefit from recognizing certain deferred tax assets, net of deferred tax liabilities, in the estimated range of $50 million to $80 million. Additionally, the Domestication caused the Company to reassess the full valuation allowance recorded against its U.S. state deferred tax assets. As a result, the Company estimates it will release approximately $50 million of its valuation allowance recorded against its U.S. state deferred tax assets, which will be an additional discrete benefit and is not included in the disclosed range above. These discrete benefits will be recorded during the third quarter of 2020.
26
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
You should read the following discussion in conjunction with our audited historical consolidated financial statements, which are included in the 2019 Form 10-K and our unaudited consolidated financial statements for the fiscal quarter ended July 3, 2020 included elsewhere in this Form 10-Q. This Management's Discussion and Analysis of Financial Condition and Results of Operations contains statements that are forward-looking. These statements are based on current expectations and assumptions that are subject to risks, uncertainties and other factors. Actual results could differ materially because of the factors discussed below or elsewhere in this Form 10-Q. See Part II, Item 1A. "Risk Factors" of this Form 10-Q and Part I, Item 1A. "Risk Factors" of the 2019 Form 10-K.
Executive Overview
ON Semiconductor Overview
ON Semiconductor is driving innovation in energy-efficient electronics. We believe that our extensive portfolio of sensors, power management, connectivity, custom and SoC, analog, logic, timing and discrete devices helps customers efficiently solve their design challenges in advanced electronic systems and products. Our power management and motor driver semiconductor components control, convert, protect and monitor the supply of power to the different elements within a wide variety of electronic devices. Our custom ASICs and SoC devices use analog, MCU, DSP, mixed-signal and advanced logic capabilities to enable the application and uses of many of our automotive, medical, aerospace/defense, consumer and industrial customers’ products. Our signal management semiconductor components provide high-performance clock management and data flow management for precision computing, communications and industrial systems. Our portfolio of sensors, including image sensors, radar and LiDAR, provide advanced solutions for automotive, industrial and IoT applications. Our standard semiconductor components serve as “building blocks” within virtually all types of electronic devices. These various products fall into the logic, analog, discrete, image sensors, IoT, Wi-Fi and memory categories used by the WSTS group.
We serve a broad base of end-user markets, including automotive, communications, computing, consumer, medical, industrial, networking, telecom and aerospace/defense. Our devices are found in a wide variety of end products, including life-saving medical devices, automobiles, smartphones, data center and enterprise servers, wearable medical devices, personal computers, industrial building and home automation systems, factory automation, consumer white goods, security and surveillance systems, machine vision and robotics, LED lighting, power supplies, networking and telecom equipment, medical diagnostics and imaging and hearing health.
Our portfolio of devices enables us to offer advanced ICs and the "building block" components that deliver system level functionality and design solutions. We shipped approximately 30.0 billion units during the six months ended July 3, 2020, as compared to 31.9 billion units during the six months ended June 28, 2019, resulting in a period-over-period decrease of approximately 6%. We offer micro packages, which provide increased performance characteristics while reducing the critical board space inside today's ever-shrinking electronic devices and power modules, delivering improved energy efficiency and reliability for a wide variety of medium and high power applications. We believe that our ability to offer a broad range of products, combined with our applications and global manufacturing and logistics network, provides our customers with single source purchasing on a cost-effective and timely basis.
As many of our products are sold into different end-markets, the total revenue reported for a segment is not indicative of actual sales in the end-market associated with that segment, but rather is the sum of the revenue from the product lines assigned to that segment. From time to time, we reassess the alignment of our product families and devices to our operating segments and may move product families or individual devices from one operating segment to another. As of July 3, 2020, we were organized into the following three operating and reportable segments: PSG, ASG and ISG.
Business and Macroeconomic Environment
During the quarter ended July 3, 2020, the impact of the COVID-19 pandemic and the resulting geopolitical and macroeconomic factors continued to manifest in the form of decreased demand for products in the semiconductor industry. The severity and duration of these economic repercussions remain largely unknown and ultimately will depend on many factors, including the speed and effectiveness of the COVID-19 pandemic containment efforts throughout the world. Our operations might be negatively impacted by, among other things, the decrease in production levels and increased costs resulting from our efforts to mitigate the impact of the COVID-19 pandemic through social-distancing measures we have enacted at certain of our locations around the world. We also believe, however, that secular trends in the automotive, industrial, and cloud-power end-markets will continue to drive long-term growth in the semiconductor industry.
27
During portions of the first and second quarters of 2020, in an effort to contain and slow the spread of the COVID-19 pandemic, governments around the world enacted various measures, including orders to close all businesses not deemed “essential,” quarantine residents in their homes or places of residence, and practice social distancing when engaging in essential activities. While many of these measures have been relaxed in certain jurisdictions, the extent to which COVID-19 will impact demand for our products depends on future developments, which are highly uncertain and difficult to predict, including new information that may emerge concerning the severity of the COVID-19 pandemic and actions to contain and treat its impacts, as well as the potential impact of a second wave of infection. In response to market and industry trends, we have pursued, and expect to continue to pursue, cost-saving initiatives to align our overall cost structure, capital investments and other expenditures with our expected revenue, spending and capacity levels based on our current sales and manufacturing projections. We have historically taken and continue to take significant cost containment efforts, including, but not limited to, workforce reductions, reducing discretionary spending, furloughs, and mandatory vacations. While all our global manufacturing sites are currently operational, our facilities could be required to temporarily curtail production levels or temporarily cease operations based on government mandates. There can be no assurances that we will adequately forecast the impact of adverse economic conditions on our business or that we will effectively align our cost structure, capital investments and other expenditures with our revenue, spending and capacity levels in the future. With the expected completion of the 300mm fab acquisition in East Fishkill, New York towards the end of 2022, we began to consolidate and make structural changes to our manufacturing footprint. During February 2020, we announced that we were exploring the sale of our six-inch fab in Belgium. Also, in August 2020, we announced the plan to explore the sale of our six-inch fab in Niigata, Japan. Production from the Belgium and Niigata fabs will be transitioned to other fabs in our manufacturing network. The active marketing and the eventual disposition of these facilities may result in accounting charges in the future.
The Impact of the COVID-19 Pandemic to our Industry
While the full extent of the COVID-19 pandemic’s impact on global supply chains and global growth remains to be seen, events surrounding the pandemic have reduced economic activity across the globe. While there has been some increased demand in the areas of business that support the stay-at-home economy, such as products used in data center infrastructure, notebook computers, and similar applications, demand in other categories such as automotive, smartphones and consumer electronics has decreased. While the majority of companies have sought to manage the disruptions caused by the COVID-19 pandemic by implementing contingency plans in the near-term, in the long-term, we believe that, companies are likely to re-assess and consider modifying their supply chain strategies and operating models to mitigate single points of failure.
The Impact of the COVID-19 Pandemic on our Business
The COVID-19 pandemic continues to impact our business and the uncertainty regarding the duration, severity, and possible resurgence of the pandemic in future periods is still unclear. In addition to the impact of lower demand, we continue to experience some supply chain and logistical constraints on procurement of certain materials. We expect these conditions to continue in varying duration and severity until such time as the COVID-19 pandemic is effectively contained globally. While we believe that our business has stabilized from the impact of the pandemic, the possible resurgence could alter the business landscape again. While we anticipate an increase in economic activity depending on the rate, pace, and effectiveness of the containment efforts deployed by various national, state, and local governments, we are unable to predict the nature, timing and sustainability of an economic recovery. Our long-term fundamentals remain strong as we continue to believe we are well-positioned for growth as business conditions meaningfully improve.
In an effort to protect the health and safety of our employees, we took and continue to take proactive, aggressive actions to adopt social distancing policies at our locations around the world, including reducing the number of people in our sites at any one time, instructing or encouraging our employees to work from home where possible, limiting the number of employees attending meetings and suspending employee travel. In our role as responsible corporate citizens, we have taken actions to support our global communities by providing essential medical supplies and by donating N95 masks, ActiveAir masks, surgical masks, smocks, hand sanitizers, hairnets, nitrile gloves and medical protection suits to hospitals and health workers. We will continue to actively monitor implications of the COVID-19 pandemic on our and our customers’ businesses and may take further actions to alter our business operations if we determine that such alterations are in the best interests of our employees, customers, partners, suppliers, and stakeholders, or as required by federal, state, or local authorities. It is not clear what the potential effects of such alterations or modifications may have on our business for the remainder of 2020 or thereafter, including the effects on our customers, employees, and prospects, or on our financial results.
28
Results of Operations
The COVID-19 pandemic continued to impact our business operations during the quarter and six months ended July 3, 2020. Among others, we experienced the impact in the form of decreased demand for some of our products, supply chain constraints in shipment and procurement of materials and lower factory utilization due to governmental regulations implemented to slow and contain the spread of the COVID-19 pandemic during portions of the first and second quarters. While we have taken numerous steps to navigate through the challenges faced and mitigate its impact, we are currently unable to estimate the ultimate potential effects on our business, customers, employees, or our future financial results.
Quarter Ended July 3, 2020 compared to the Quarter Ended June 28, 2019
The following table summarizes certain information relating to our operating results that has been derived from our unaudited consolidated financial statements (in millions):
| Quarters Ended | |||||||||||||||||||||||
| July 3, 2020 | June 28, 2019 | Dollar Change | |||||||||||||||||||||
| Revenue | $ | 1,213.5 | $ | 1,347.7 | $ | (134.2) | |||||||||||||||||
| Cost of revenue (exclusive of amortization shown below) | 839.2 | 848.7 | (9.5) | ||||||||||||||||||||
| Gross profit | 374.3 | 499.0 | (124.7) | ||||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| Research and development | 156.1 | 147.0 | 9.1 | ||||||||||||||||||||
| Selling and marketing | 65.6 | 73.6 | (8.0) | ||||||||||||||||||||
| General and administrative | 62.9 | 74.1 | (11.2) | ||||||||||||||||||||
| Amortization of acquisition-related intangible assets | 29.1 | 27.5 | 1.6 | ||||||||||||||||||||
| Restructuring, asset impairments and other charges, net | 16.2 | 18.1 | (1.9) | ||||||||||||||||||||
| Intangible asset impairment | 1.3 | 0.4 | 0.9 | ||||||||||||||||||||
| Total operating expenses | 331.2 | 340.7 | (9.5) | ||||||||||||||||||||
| Operating income | 43.1 | 158.3 | (115.2) | ||||||||||||||||||||
| Other income (expense), net: | |||||||||||||||||||||||
| Interest expense | (41.9) | (33.7) | (8.2) | ||||||||||||||||||||
| Interest income | 1.5 | 3.0 | (1.5) | ||||||||||||||||||||
| Loss on debt refinancing and prepayment | — | (0.4) | 0.4 | ||||||||||||||||||||
| Other expense | (2.8) | (1.0) | (1.8) | ||||||||||||||||||||
| Other income (expense), net | (43.2) | (32.1) | (11.1) | ||||||||||||||||||||
| Income (loss) before income taxes | (0.1) | 126.2 | (126.3) | ||||||||||||||||||||
| Income tax provision | (0.8) | (23.3) | 22.5 | ||||||||||||||||||||
| Net income (loss) | (0.9) | 102.9 | (103.8) | ||||||||||||||||||||
| Less: Net income attributable to non-controlling interest | (0.5) | (1.1) | 0.6 | ||||||||||||||||||||
| Net income (loss) attributable to ON Semiconductor Corporation | $ | (1.4) | $ | 101.8 | $ | (103.2) | |||||||||||||||||
Revenue
Revenue was $1,213.5 million and $1,347.7 million for the quarters ended July 3, 2020 and June 28, 2019, respectively, representing a decrease of $134.2 million, or approximately 10%. We had one customer, a distributor, whose revenue accounted for approximately 11% of the total revenue for the quarter ended July 3, 2020.
29
Revenue by operating and reportable segments was as follows (dollars in millions):
| Quarter Ended July 3, 2020 | As a % of Total Revenue (1) | Quarter Ended June 28, 2019 | As a % of Total Revenue (1) | ||||||||||||||||||||
| PSG | $ | 618.4 | 51.0 | % | $ | 700.9 | 52.0 | % | |||||||||||||||
| ASG | 426.7 | 35.2 | % | 462.0 | 34.3 | % | |||||||||||||||||
| ISG | 168.4 | 13.9 | % | 184.8 | 13.7 | % | |||||||||||||||||
| Total revenue | $ | 1,213.5 | $ | 1,347.7 | |||||||||||||||||||
(1) Certain amounts may not total due to rounding of individual amounts.
Revenue from PSG decreased by $82.5 million, or approximately 12%, for the quarter ended July 3, 2020 compared to the quarter ended June 28, 2019. The revenue from our Advanced Power Division and Protection and Signal Division decreased by $42.8 million and $19.1 million, respectively. The decreases were due to a combination of a general decline in demand for these products due to prevailing economic conditions caused by the COVID-19 pandemic and the impact of delays in fulfilling certain customer orders due to our factories in the Philippines and Malaysia operating at significantly reduced capacity levels during the first half of the second quarter of 2020 as a result of the COVID-19 pandemic.
Revenue from ASG decreased by $35.3 million, or approximately 8%, for the quarter ended July 3, 2020 compared to the quarter ended June 28, 2019. The revenue from our Automotive Division and Mobile, Computing and Cloud Division decreased by $40.4 million and $7.1 million, respectively. These decreases were partially offset by an increase in revenue of $16.3 million in our Wireless Connectivity Solutions Division, which included the acquired Quantenna business. The decrease in demand for the Automotive division products was due to the significant issues faced by Automotive component manufacturers and the overall Automotive industry as a result of the COVID-19 pandemic. This was exacerbated by delays in fulfilling certain customer orders due to our factories in the Philippines and Malaysia operating at significantly reduced capacity levels during the first half of the second quarter of 2020 as a result of the COVID-19 pandemic.
Revenue from ISG decreased by $16.4 million, or approximately 9%, for the quarter ended July 3, 2020 compared to the quarter ended June 28, 2019. The revenue from our Automotive Solutions Division and Consumer Solutions Division decreased by $10.4 million and $10.3 million, respectively. These decreases in revenue were due to decreased demand and delays in fulfilling certain customer orders due to supply chain constraints as a result of the COVID-19 pandemic, partially offset by an increase in revenue in other divisions.
Revenue by geographic locations, based on sales billed from the respective country or regions, was as follows (dollars in millions):
| Quarter Ended July 3, 2020 | As a % of Total Revenue (1) | Quarter Ended June 28, 2019 | As a % of Total Revenue (1) | ||||||||||||||||||||
| Singapore | $ | 439.4 | 36.2 | % | $ | 379.9 | 28.2 | % | |||||||||||||||
| Hong Kong | 323.3 | 26.6 | % | 348.4 | 25.9 | % | |||||||||||||||||
| United Kingdom | 140.9 | 11.6 | % | 229.4 | 17.0 | % | |||||||||||||||||
| United States | 151.8 | 12.5 | % | 223.5 | 16.6 | % | |||||||||||||||||
| Other | 158.1 | 13.0 | % | 166.5 | 12.4 | % | |||||||||||||||||
| Total | $ | 1,213.5 | $ | 1,347.7 | |||||||||||||||||||
(1) Certain amounts may not total due to rounding of individual amounts.
30
Gross Profit and Gross Margin (exclusive of amortization of acquisition-related intangible assets)
Our gross profit by operating and reportable segments was as follows (dollars in millions):
| Quarter Ended July 3, 2020 | As a % of Segment Revenue (1) | Quarter Ended June 28, 2019 | As a % of Segment Revenue (1) | ||||||||||||||||||||
| PSG | $ | 184.2 | 29.8 | % | $ | 255.7 | 36.5 | % | |||||||||||||||
| ASG | 156.1 | 36.6 | % | 184.7 | 40.0 | % | |||||||||||||||||
| ISG | 50.3 | 29.9 | % | 65.9 | 35.7 | % | |||||||||||||||||
| Gross profit for all segments | $ | 390.6 | $ | 506.3 | |||||||||||||||||||
| Unallocated manufacturing costs | (16.3) | (1.3) | % | (7.3) | (0.5) | % | |||||||||||||||||
| Total gross profit | $ | 374.3 | 30.8 | % | $ | 499.0 | 37.0 | % | |||||||||||||||
(1) Certain amounts may not total due to rounding of individual amounts.
Our gross profit decreased by $124.7 million, or approximately 25%, from $499.0 million for the quarter ended June 28, 2019 to $374.3 million for the quarter ended July 3, 2020. Gross profit as a percentage of revenue decreased to approximately 31% for the quarter ended July 3, 2020 from approximately 37% for the quarter ended June 28, 2019.
The decrease in gross profit and gross margin were attributable to multiple factors, including a significant decline in sales volume, a decline in average selling prices and under-absorbed fixed overhead in some of our manufacturing locations due to abnormally low utilization at the beginning of the second quarter of 2020. Certain of our factories in Malaysia and the Philippines had to temporarily shut down or operate at a significantly reduced capacity due to the COVID-19 pandemic during the first half of the second quarter of 2020. As a result, during the quarter ended July 3, 2020, we recorded approximately $13 million of fixed overhead charges directly to cost of revenues, representing under-absorbed inventory costs due to the COVID-19 pandemic.
Operating Expenses
The general cost-saving measures initiated by the Company in response to the COVID-19 pandemic had a meaningful impact on selling and marketing expenses and general and administrative expenses for the quarter ended July 3, 2020 compared to the quarter ended June 28, 2019.
Research and development expenses were $156.1 million for the quarter ended July 3, 2020, as compared to $147.0 million for the quarter ended June 28, 2019, representing an increase of $9.1 million, or approximately 6%. This increase was primarily due to the inclusion of the Quantenna employees in the headcount for the entire quarter ended July 3, 2020, resulting in higher payroll costs. This increase in payroll was partially offset by a decrease in expenses in other categories due to the cost-saving measures initiated by the Company.
Selling and marketing expenses were $65.6 million for the quarter ended July 3, 2020, as compared to $73.6 million for the quarter ended June 28, 2019, representing a decrease of $8.0 million, or approximately 11%. The decrease was in the areas of payroll and travel-related expenses due to the cost-saving measures initiated by the Company and travel restrictions implemented in response to the COVID-19 pandemic.
General and administrative expenses were $62.9 million for the quarter ended July 3, 2020, as compared to $74.1 million for the quarter ended June 28, 2019, representing a decrease of $11.2 million, or approximately 15%. This decrease was primarily attributable to a decrease in stock compensation expense and in certain other categories due to the cost-saving measures initiated by the Company.
Other Operating Expenses
Amortization of Acquisition-Related Intangible Assets
Amortization of acquisition-related intangible assets was $29.1 million for the quarter ended July 3, 2020, as compared to $27.5 million for the quarter ended June 28, 2019. The increase of $1.6 million, or approximately 6%, was primarily due to the amortization of our intangible assets acquired from Quantenna.
31
Restructuring, Asset Impairments and Other, Net
Restructuring, asset impairments and other, net was $16.2 million for the quarter ended July 3, 2020, as compared to $18.1 million for the quarter ended June 28, 2019, representing costs related to the restructuring programs in effect during the respective quarters. For additional information, see Note 5: ''Restructuring, Asset Impairments and Other, Net'' in the notes to our unaudited consolidated financial statements included elsewhere in this Form 10-Q.
Interest Expense
Interest expense increased by $8.2 million to $41.9 million during the quarter ended July 3, 2020, as compared to $33.7 million during the quarter ended June 28, 2019. The increase was due to the interest for the additional debt incurred for the acquisition of Quantenna and the Credit Facility Draw. Our average gross long-term debt balance (including current maturities) for the quarter ended July 3, 2020 was $4,855.4 million at a weighted-average interest rate of 3.5%, as compared to $3,368.5 million at a weighted-average interest rate of 4.0% for the quarter ended June 28, 2019.
Income Taxes Provision and Benefit
We recorded an income tax provision of $0.8 million and $23.3 million during the quarters ended July 3, 2020 and June 28, 2019, respectively.
The income tax provision for the quarter ended July 3, 2020 consisted of $0.9 million for income and withholding taxes of certain of our foreign and domestic operations offset by $0.1 million of discrete benefits.
The income tax provision for the quarter ended June 28, 2019 consisted of $25.6 million for income and withholding taxes of certain of our foreign and domestic operations and $1.4 million of new reserves and interest on existing reserves for uncertain tax positions in foreign jurisdictions. These amounts were offset by discrete benefits of $3.4 million relating to the release of reserves and interest for uncertain tax positions in foreign jurisdictions related to prior years and $0.3 million relating to equity award excess tax benefits.
For additional information, see Note 13: ''Income Taxes'' and Note 15: ''Subsequent Event'' in the notes to the unaudited consolidated financial statements included elsewhere in this Form 10-Q.
32
Results of Operations
Six Months Ended July 3, 2020 compared to the Six Months Ended June 28, 2019
The following table summarizes certain information relating to our operating results that has been derived from our unaudited consolidated financial statements (in millions):
| Six Months Ended | |||||||||||||||||||||||
| July 3, 2020 | June 28, 2019 | Dollar Change | |||||||||||||||||||||
| Revenue | $ | 2,491.4 | $ | 2,734.3 | $ | (242.9) | |||||||||||||||||
| Cost of revenue (exclusive of amortization shown below) | 1,714.4 | 1,721.6 | (7.2) | ||||||||||||||||||||
| Gross profit | 777.0 | 1,012.7 | (235.7) | ||||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| Research and development | 327.1 | 298.8 | 28.3 | ||||||||||||||||||||
| Selling and marketing | 142.4 | 150.7 | (8.3) | ||||||||||||||||||||
| General and administrative | 134.1 | 147.0 | (12.9) | ||||||||||||||||||||
| Amortization of acquisition-related intangible assets | 61.4 | 53.2 | 8.2 | ||||||||||||||||||||
| Restructuring, asset impairments and other charges, net | 49.0 | 23.7 | 25.3 | ||||||||||||||||||||
| Intangible asset impairment | 1.3 | 1.6 | (0.3) | ||||||||||||||||||||
| Total operating expenses | 715.3 | 675.0 | 40.3 | ||||||||||||||||||||
| Operating income | 61.7 | 337.7 | (276.0) | ||||||||||||||||||||
| Other income (expense), net: | |||||||||||||||||||||||
| Interest expense | (84.4) | (65.4) | (19.0) | ||||||||||||||||||||
| Interest income | 3.4 | 5.5 | (2.1) | ||||||||||||||||||||
| Loss on debt refinancing and prepayment | — | (0.4) | 0.4 | ||||||||||||||||||||
| Other income (expense) | (2.7) | 1.1 | (3.8) | ||||||||||||||||||||
| Other income (expense), net | (83.7) | (59.2) | (24.5) | ||||||||||||||||||||
| Income (loss) before income taxes | (22.0) | 278.5 | (300.5) | ||||||||||||||||||||
| Income tax benefit (provision) | 7.4 | (61.5) | 68.9 | ||||||||||||||||||||
| Net income (loss) | (14.6) | 217.0 | (231.6) | ||||||||||||||||||||
| Less: Net income attributable to non-controlling interest | (0.8) | (1.1) | 0.3 | ||||||||||||||||||||
| Net income (loss) attributable to ON Semiconductor Corporation | $ | (15.4) | $ | 215.9 | $ | (231.3) | |||||||||||||||||
Revenue
Revenue was $2,491.4 million and $2,734.3 million for the six months ended July 3, 2020 and June 28, 2019, respectively, representing a decrease of $242.9 million, or 8.9%. We had one customer, a distributor, whose revenue accounted for approximately 10% of the total revenue for the six months ended July 3, 2020.
Revenue by operating and reportable segments was as follows (dollars in millions):
| Six Months Ended July 3, 2020 | As a % of Total Revenue (1) | Six Months Ended June 28, 2019 | As a % of Total Revenue (1) | ||||||||||||||||||||
| PSG | $ | 1,242.3 | 49.9 | % | $ | 1,405.1 | 51.4 | % | |||||||||||||||
| ASG | 893.8 | 35.9 | % | 956.1 | 35.0 | % | |||||||||||||||||
| ISG | 355.3 | 14.3 | % | 373.1 | 13.6 | % | |||||||||||||||||
| Total revenue | $ | 2,491.4 | $ | 2,734.3 | |||||||||||||||||||
(1) Certain amounts may not total due to rounding of individual amounts.
Revenue from PSG decreased by $162.8 million, or approximately 12%, for the six months ended July 3, 2020 compared to the six months ended June 28, 2019. The revenue from our Advanced Power Division and Protection and Signal Division decreased by $90.6 million and $40.7 million, respectively. The decreases were due to a combination of a general decline in demand for
33
these products due to prevailing economic conditions caused by the COVID-19 pandemic and the impact of delays in fulfilling certain customer orders due to our factories in China, the Philippines and Malaysia operating at significantly reduced capacity levels during portions of the first and second quarters of 2020 as a result of the COVID-19 pandemic.
Revenue from ASG decreased by $62.3 million, or approximately 7%, for the six months ended July 3, 2020 compared to the six months ended June 28, 2019. The revenue from our Automotive Division, Industrial and Offline Power Division and our Mobile, Computing and Cloud Division decreased by $47.4 million, $25.4 million and $42.3 million, respectively. These decreases were partially offset by an increase in revenue of $53.3 million in our Wireless Connectivity Solutions Division, which included the acquired Quantenna business. The decrease in demand for the products in the Automotive division was primarily due to the significant issues faced by Automotive manufacturers as a result of the COVID-19 pandemic. This was exacerbated by delays in fulfilling certain customer orders due to our factories in China, the Philippines and Malaysia operating at a significantly reduced capacity levels as a result of the COVID-19 pandemic.
Revenue from ISG decreased by $17.8 million, or approximately 5%, for the six months ended July 3, 2020 compared to the six months ended June 28, 2019. The revenue from our Automotive Solutions Division and Consumer Solutions Division decreased by $17.0 million and $9.6 million, respectively. These decreases in revenue were due to decreased demand and delays in fulfilling certain customer orders due to supply chain constraints as a result of the COVID-19 pandemic, and was partially offset by an increase in revenue in other divisions.
Revenue by geographic location, including local sales made by operations within each area, based on sales billed from the respective region, was as follows (dollars in millions):
| Six Months Ended July 3, 2020 | As a % of Total Revenue (1) | Six Months Ended June 28, 2019 | As a % of Total Revenue (1) | ||||||||||||||||||||
| Singapore | $ | 847.7 | 34.0 | % | $ | 805.1 | 29.4 | % | |||||||||||||||
| Hong Kong | 639.5 | 25.7 | % | 686.4 | 25.1 | % | |||||||||||||||||
| United Kingdom | 367.9 | 14.8 | % | 476.3 | 17.4 | % | |||||||||||||||||
| United States | 336.3 | 13.5 | % | 437.1 | 16.0 | % | |||||||||||||||||
| Other | 300.0 | 12.0 | % | 329.4 | 12.0 | % | |||||||||||||||||
| Total | $ | 2,491.4 | $ | 2,734.3 | |||||||||||||||||||
(1) Certain amounts may not total due to rounding of individual amounts.
Gross Profit and Gross Margin (exclusive of amortization of acquisition-related intangible assets described below)
Our gross profit by operating and reportable segments was as follows (dollars in millions):
| Six Months Ended July 3, 2020 | As a % of Segment Revenue (1) | Six Months Ended June 28, 2019 | As a % of Segment Revenue (1) | ||||||||||||||||||||
| PSG | $ | 362.8 | 29.2 | % | $ | 504.7 | 35.9 | % | |||||||||||||||
| ASG | 330.9 | 37.0 | % | 384.8 | 40.2 | % | |||||||||||||||||
| ISG | 113.1 | 31.8 | % | 140.8 | 37.7 | % | |||||||||||||||||
| Gross profit | $ | 806.8 | $ | 1,030.3 | |||||||||||||||||||
| Unallocated manufacturing costs | (29.8) | (1.2) | % | (17.6) | (0.6) | % | |||||||||||||||||
| Consolidated gross profit | $ | 777.0 | 31.2 | % | $ | 1,012.7 | 37.0 | % | |||||||||||||||
(1) Certain amounts may not total due to rounding of individual amounts.
Our gross profit was $777.0 million for the six months ended July 3, 2020 compared to $1,012.7 million for the six months ended June 28, 2019. Gross profit decreased by $235.7 million, or approximately 23%. Gross profit as a percentage of revenue decreased to approximately 31% for the six months ended July 3, 2020 from approximately 37% for the six months ended June 28, 2019.
The decrease in gross profit and gross margin were attributable to multiple factors, including a significant decline in sales volume, a decline in average selling prices and under absorbed fixed overhead in some of our manufacturing locations due to abnormally low utilization during the first and second quarters of 2020. Certain of our factories in China, Malaysia and the Philippines had to temporarily shut down or operate at a significantly reduced capacity due to the COVID-19 pandemic during
34
portions of the first and second quarters of 2020. As a result, we recorded approximately $33 million of fixed overhead charges directly to cost of revenues, representing under absorbed inventory costs due to the COVID-19 pandemic, during the six months ended July 3, 2020.
Operating Expenses
The general cost-saving measures initiated by the Company in response to the COVID-19 pandemic had a meaningful impact on selling and marketing expenses and general and administrative expenses for the six months ended July 3, 2020 compared to the six months ended June 28, 2019.
Research and development expenses were $327.1 million for the six months ended July 3, 2020, as compared to $298.8 million for the six months ended June 28, 2019, representing an increase of $28.3 million, or approximately 9%. This increase was primarily due to the addition of Quantenna employees in the headcount for the entire six months ended July 3, 2020, resulting in higher payroll costs.
Selling and marketing expenses were $142.4 million for the six months ended July 3, 2020, as compared to $150.7 million for the six months ended June 28, 2019, representing a decrease of $8.3 million, or approximately 6%. The decrease was primarily in travel-related expenses due to the cost-saving measures initiated by the Company and travel restrictions implemented in response to the COVID-19 pandemic.
General and administrative expenses were $134.1 million for the six months ended July 3, 2020, as compared to $147.0 million in the six months ended June 28, 2019, representing a decrease of $12.9 million, or approximately 9%. This decrease was primarily attributable to a decrease in stock compensation expense and in certain other categories due to the cost-saving measures initiated by the Company.
Other Operating Expenses
Amortization of Acquisition-Related Intangible Assets
Amortization of acquisition-related intangible assets was $61.4 million and $53.2 million for the six months ended July 3, 2020 and June 28, 2019, respectively, representing a period-over-period increase of $8.2 million, or approximately 15%. The increase was primarily due to the amortization of our intangible assets acquired from Quantenna.
Restructuring, Asset Impairments and Other, Net
Restructuring, asset impairments and other, net was $49.0 million for the six months ended July 3, 2020, as compared to $23.7 million for the six months ended June 28, 2019, representing an increase of $25.3 million. The increase was primarily due to the restructuring costs relating to the VSP and ISP. For additional information, see Note 5: ''Restructuring, Asset Impairments and Other, Net'' in the notes to our unaudited consolidated financial statements included elsewhere in this Form 10-Q.
Goodwill and Intangible Asset Impairment
Intangible asset impairment was $1.3 million for the six months ended July 3, 2020, as compared to $1.6 million for the six months ended June 28, 2019.
Interest Expense
Interest expense increased by $19.0 million to $84.4 million during the six months ended July 3, 2020, as compared to $65.4 million during the six months ended June 28, 2019. The increase was due to the additional debt incurred for the acquisition of Quantenna and the Credit Facility Draw. Our average gross long-term debt balance (including current maturities) for the six months ended July 3, 2020 was $4,301.2 million at a weighted-average interest rate of 3.9%, as compared to $3,372.4 million at a weighted-average interest rate of 3.9% for the six months ended June 28, 2019.
Loss on Debt Refinancing and Prepayment
Loss on debt refinancing was zero for the six months ended July 3, 2020, as compared to $0.4 million for the six months ended June 28, 2019.
35
Other Income (Expense)
Other income (expense) decreased by $3.8 million to expense of $2.7 million for the six months ended July 3, 2020, compared to income of $1.1 million for the six months ended June 28, 2019.
Income Tax Provision and Benefit
We recorded an income tax benefit of $7.4 million and a provision of $61.5 million during the six months ended July 3, 2020 and June 28, 2019, respectively.
The income tax benefit for the six months ended July 3, 2020 consisted of a benefit of $7.5 million for income and withholding taxes of certain of our foreign and domestic operations partially offset by $0.1 million of discrete expenses.
The income tax provision for the six months ended June 28, 2019 consisted of $61.6 million for income and withholding taxes of certain of our foreign and domestic operations, $6.0 million relating to the resolution of a foreign tax dispute, $2.3 million of new reserves and interest on existing reserves for uncertain tax positions in foreign jurisdictions, and $0.4 million of prior year adjustments. These amounts were offset by discrete benefits of $3.4 million relating to the release of reserves and interest for uncertain tax positions in foreign jurisdictions related to prior years and $5.4 million relating to equity award excess tax benefits.
For additional information, see Note 13: ''Income Taxes'' and Note 15: "Subsequent Event" in the notes to the unaudited consolidated financial statements included elsewhere in this Form 10-Q.
Liquidity and Capital Resources
This section includes a discussion and analysis of our cash requirements, off-balance sheet arrangements, contingencies, sources and uses of cash, operations, working capital and long-term assets and liabilities.
Contractual Obligations
As of July 3, 2020, there were no material changes outside the ordinary course of business to the contractual obligations table, including the notes thereto, contained in the 2019 Form 10-K.
Off-Balance Sheet Arrangements
In the ordinary course of business, we provide standby letters of credit or other guarantee instruments to certain parties in connection with certain transactions, including, but not limited to, material purchase commitments, agreements to mitigate collection risk, leases, utilities or customs guarantees. As of July 3, 2020, the Company's Revolving Credit Facility included $15.0 million of commitment subject to the available balance of the Revolving Credit Facility for the issuance of letters of credit, which, as of the date of this Form 10-Q was $4.0 million. There were $1.0 million letters of credit outstanding under the Revolving Credit Facility as of July 3, 2020, which reduced the Company's borrowing capacity. As of July 3, 2020, we also had outstanding guarantees and letters of credit outside of our Revolving Credit Facility in the amount of $6.8 million.
As part of securing financing in the ordinary course of business, we have issued guarantees related to certain of our subsidiaries' term loan financing and surety bond, which totaled $1.4 million as of July 3, 2020. Based on historical experience and information currently available, we believe that we will not be required to make payments under the standby letters of credit or guarantee arrangements for the foreseeable future.
We have not recorded any liability in connection with these letters of credit and guarantee arrangements. See Note 7: ''Long-Term Debt'' and Note 10: ''Commitments and Contingencies'' in the notes to our unaudited consolidated financial statements included elsewhere in this Form 10-Q for additional information.
Contingencies
We are a party to a variety of agreements entered into in the ordinary course of business pursuant to which we may be obligated to indemnify other parties for certain liabilities that arise out of or relate to the subject matter of the agreements. Some of the agreements entered into by us require us to indemnify the other party against losses due to IP infringement, environmental contamination and other property damage, personal injury, our failure to comply with applicable laws, our negligence or willful misconduct or our breach of representations, warranties or covenants related to such matters as title to sold assets.
36
We face risk of exposure to warranty and product liability claims in the event that our products fail to perform as expected or such failure of our products results, or is alleged to result, in economic damage, bodily injury or property damage. In addition, if any of our designed products are alleged to be defective, we may be required to participate in their recall. Depending on the significance of any particular customer and other relevant factors, we may agree to provide more favorable rights to such customer for valid defective product claims.
We maintain directors’ and officers’ insurance policies that indemnify our directors and officers against various liabilities, including certain liabilities under the Exchange Act, that might be incurred by any director or officer in his or her capacity as such.
The Fairchild Agreement provides for indemnification and insurance rights in favor of Fairchild’s then current and former directors, officers and employees. Specifically, we have agreed that, for no fewer than six years following the Fairchild acquisition, we will: (a) indemnify and hold harmless each such indemnitee against losses and expenses (including advancement of attorneys’ fees and expenses) in connection with any proceeding asserted against the indemnified party in connection with such person’s servings as a director, officer, employee or other fiduciary of Fairchild or its subsidiaries prior to the effective time of the acquisition; (b) maintain in effect all provisions of the certificate of incorporation or bylaws of Fairchild or any of its subsidiaries or any other agreements of Fairchild or any of its subsidiaries with any indemnified party regarding elimination of liability, indemnification of officers, directors and employees and advancement of expenses in existence on the date of the Fairchild Agreement for acts or omissions occurring prior to the effective time of the acquisition and; (c) subject to certain qualifications, provide to Fairchild’s then current directors and officers an insurance and indemnification policy that provides coverage for events occurring prior to the effective time of the acquisition that is no less favorable than Fairchild’s then-existing policy, or, if insurance coverage that is no less favorable is unavailable, the best available coverage.
Similarly, the Quantenna Agreement provides for indemnification and insurance rights in favor of Quantenna’s then current and former directors, officers, employees and agents. Specifically, the Company has agreed that, for no fewer than six years following the Quantenna acquisition, the Company will: (a) indemnify and hold harmless each such indemnified party to the fullest extent permitted by Delaware law in the event of any threatened or actual claim suit, action, proceeding or investigation against the indemnified party based in whole or in part on, or pertaining to, such person’s serving as a director, officer, employee or agent of Quantenna or its subsidiaries or predecessors prior to the effective time of the acquisition or in connection with the Quantenna Agreement; (b) maintain in effect provisions of the certificate of incorporation and bylaws of Quantenna and each of its subsidiaries regarding the elimination of liability of directors and indemnification of officers, directors and employees that are no less advantageous to the intended beneficiaries than the corresponding provisions in the certificate of incorporation and bylaws of Quantenna and each of its subsidiaries in existence on the date of the Quantenna Agreement; and (c) obtain and fully pay the premium for a non-cancelable extension of directors’ and officers’ liability coverage of Quantenna’s directors’ and officers’ policies and Quantenna’s fiduciary liability insurance policies in effect as of the date of the Quantenna Agreement.
While our future obligations under certain agreements may contain limitations on liability for indemnification, other agreements do not contain such limitations, and under such agreements, it is not possible to predict the maximum potential amount of future payments due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, payments made by us under any of these indemnities have not had a material effect on our business, financial condition, results of operations or cash flows, and we do not believe that any amounts that we may be required to pay under these indemnities in the future will be material to our business, financial condition, results of operations or cash flows.
See Note 10: ''Commitments and Contingencies'' in the notes to our unaudited consolidated financial statements under the heading "Legal Matters" included elsewhere in this Form 10-Q for possible contingencies related to legal matters. See also Part I, Item 1 "Business - Government Regulation" of the 2019 Form 10-K for information on certain environmental matters.
Sources and Uses of Cash
Our balance of cash and cash equivalents was $2,060.4 million as of July 3, 2020. On March 24, 2020, we borrowed $1,165.0 million under the Revolving Credit Facility as a precautionary measure in order to increase our cash position and provide financial flexibility in light of the uncertainty from the impact of the COVID-19 pandemic ("Credit Facility Draw"). We believe that our existing cash and cash equivalents, coupled with our cash flows from operations will be adequate to fund our operations, debt repayment and capital needs, as well as to enable us to maintain compliance with our various debt agreements, through at least the next 12 months. To the extent that results or events differ from our financial projections or business plans, our liquidity may be adversely impacted. Total cash and cash equivalents as of July 3, 2020 include approximately $1.4 billion
37
available within the United States. We also have the ability to obtain additional cash in the United States to cover our domestic needs through distributions from our foreign subsidiaries, new bank loans or debt obligations.
We require cash to fund our operating expenses, working capital requirements, outlays for strategic acquisitions and investments, for debt service including principal and interest, for research and development, to make capital expenditures, and to repurchase our common stock. As a result of the Credit Facility Draw, as of March 24, 2020, we had borrowed substantially all amounts available under the Revolving Credit Facility. As of the date of this Form 10-Q, we have $4.0 million available under the Revolving Credit Facility, subject to certain conditions. The proceeds from the Credit Facility Draw could be used to repay portions of debt maturing in 2020, and for working capital, general corporate or other purposes. We expect interest expense to remain significant in future periods as we continue to service our debt.
Our principal sources of liquidity are the cash and cash equivalents on hand, cash generated from operations and funds from external borrowings and equity issuances. In the near term, we expect to fund our primary cash requirements through cash generated from operations and with cash and cash equivalents on hand.
We believe that the key factors that could affect our internal and external sources of cash include:
•Geopolitical and macroeconomic factors caused by the COVID-19 pandemic which has had, and is expected to continue to have, negative impacts on the economies of the majority of countries and industries. The potential effect of this pandemic and the responses of various governmental entities and industries thereto, the duration and severity of the pandemic, the possibility of the re-emergence of the pandemic in future months and the anticipated recovery period is uncertain.
•Factors that affect our results of operations and cash flows, including the impact on our business and operations as a result of changes in demand for our products, including as a result of the COVID-19 pandemic, competitive pricing pressures, effective management of our manufacturing capacity, our ability to achieve further reductions in operating expenses, the impact of our restructuring programs on our production and cost efficiency and our ability to make the research and development expenditures required to remain competitive in our business; and
•Factors that affect our access to bank financing and the debt and equity capital markets that could impair our ability to obtain needed financing on acceptable terms or to respond to business opportunities and developments as they arise, including interest rate fluctuations, macroeconomic conditions, including as a result of the COVID-19 pandemic, sudden reductions in the general availability of lending from banks or the related increase in cost to obtain bank financing and our ability to maintain compliance with covenants under our debt agreements in effect from time to time.
The holders of our 1.00% Notes may submit them for conversion on or after September 1, 2020. The 1.00% Notes will mature on December 1, 2020. Our ability to service our long-term debt, including our 1.625% Notes, 1.00% Notes, Revolving Credit Facility and Term Loan "B" Facility, to remain in compliance with the various covenants contained in our debt agreements and to fund working capital, capital expenditures and business development efforts will depend on our ability to generate cash from operating activities, which is subject to, among other things, our future operating performance, timing of the full economic recovery from the COVID-19 pandemic, as well as to financial, competitive, legislative, regulatory and other conditions, some or all of which may be beyond our control.
If we fail to generate sufficient cash from operations, we may need to raise additional equity or borrow additional funds to achieve our longer term objectives. While we have observed some recent stabilization in the capital markets impacted by the COVID-19 pandemic, there can be no assurance that equity or borrowings will be available when we access the capital markets or, if available, will be at rates or prices acceptable to us.
During the ordinary course of business, we evaluate our cash requirements and, if necessary, adjust our expenditures for inventory, operating expenditures and capital expenditures to reflect the current market conditions and our projected sales and demand. Our capital expenditures are primarily directed towards manufacturing equipment and capacity expansion. Our capital expenditure levels can materially influence our available cash for other initiatives. For example, during the six months ended July 3, 2020, we paid $205.6 million for capital expenditures, while during the six months ended June 28, 2019, we paid $310.5 million for capital expenditures. Our current minimum contractual capital expenditure commitment for the remainder of 2020 and 2021 and thereafter is approximately $33.1 million and $26.5 million, respectively. We revised our forecast to reflect the current developments due to the COVID-19 pandemic, and currently expect to incur capital expenditures of approximately 7% to 8% of revenue for the remainder of 2020. Future capital expenditures may be impacted by events and transactions that are not currently forecasted.
38
Primary Cash Flow Sources
Our long-term cash generation is dependent on the ability of our operations to generate cash. Our cash flows from operating activities were $320.5 million and $360.8 million for the six months ended July 3, 2020 and June 28, 2019, respectively. The decrease of $40.3 million was primarily attributable to a significant reduction in net income due to decreased demand for our products, offset by effective working capital management and the non-payment of variable compensation during 2020 compared to 2019. Our ability to maintain positive operating cash flows is dependent on, among other factors, our success in achieving our revenue goals and manufacturing and operating cost targets. Our management of our assets and liabilities, including both working capital and long-term assets and liabilities, also influences our operating cash flows, and each of these components is discussed below.
Working Capital
Working capital, calculated as total current assets less total current liabilities, fluctuates depending on end-market demand and our effective management of certain items such as receivables, inventory and payables. Our working capital, excluding cash and cash equivalents and the current portion of long-term debt, was $1,015.0 million at July 3, 2020 and has fluctuated between $1,043.4 million and $767.4 million at the end of each of our last eight fiscal quarters. Our working capital, including cash and cash equivalents and the current portion of long-term debt, was $2,379.8 million at July 3, 2020 and has fluctuated between $2,379.8 million and $1,071.4 million at the end of each of our last eight fiscal quarters. During the six months ended July 3, 2020, our working capital was most significantly impacted by Credit Facility Draw and reduced capital expenditures. Although investments made to fund working capital will reduce our cash balances, these investments are necessary to support business and operating initiatives.
Long-Term Assets and Liabilities
Our long-term assets consist primarily of property, plant and equipment, intangible assets, deferred taxes and goodwill. Our manufacturing rationalization plans have included efforts to utilize our existing manufacturing assets and supply arrangements more efficiently. We believe that near-term access to additional manufacturing capacity, should it be required, could be readily obtained on reasonable terms through manufacturing agreements with third parties.
Our long-term liabilities, excluding long-term debt and deferred taxes, consist of liabilities under our foreign defined benefit pension plans and contingent tax reserves. In regard to our foreign defined benefit pension plans, our annual funding of these obligations is equal to the minimum amount legally required in each jurisdiction in which the plans operate. This annual amount is dependent upon numerous actuarial assumptions.
Key Financing and Capital Events
Overview
For the past several years, we have undertaken various measures to secure liquidity to pursue acquisitions, repurchase shares of our common stock, reduce interest costs, amend existing key financing arrangements and, in some cases, extend a portion of our debt maturities to continue to provide us additional operating flexibility.
Cash Management
Our ability to manage cash is limited, as our primary cash inflows and outflows are dictated by the terms of our sales and supply agreements, contractual obligations, debt instruments and legal and regulatory requirements. While we have some flexibility with respect to the timing of capital equipment purchases, we must invest in capital equipment on a timely basis to allow us to maintain our manufacturing efficiency and support our platforms for new products. We continue to hold all amounts borrowed under the Credit Facility Draw, which could be used to repay a portion of debt maturing in 2020, and for working capital, general corporate or other purposes.
Debt Guarantees and Related Covenants
As of July 3, 2020, we were in compliance with the indentures relating to our 1.00% Notes and 1.625% Notes and with covenants in the Amended Credit Agreement, including those relating to our Term Loan “B” Facility and Revolving Credit Facility, and covenants in our other debt agreements. Our 1.00% Notes and our 1.625% Notes are senior to the existing and future subordinated indebtedness of ON Semiconductor and its guarantor subsidiaries and rank equally in right of payment to
39
all of our existing and future senior debt and as unsecured obligations are subordinated to all of our existing and future secured debt to the extent of the assets securing such debt.
Recent Accounting Pronouncements
For a discussion of recent accounting pronouncements, see our 2019 Form 10-K and Note 3: "Recent Accounting Pronouncements" in the notes to our unaudited consolidated financial statements included elsewhere in this Form 10-Q.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are exposed to financial market risks, including changes in interest rates and foreign currency exchange rates. To mitigate these risks, we utilize derivative financial instruments. We do not use derivative financial instruments for speculative or trading purposes.
As of July 3, 2020, our long-term debt (including current maturities) totaled $4,853.2 million. We have no interest rate exposure to rate changes on our fixed rate debt, which totaled $3,515.0 million as of July 3, 2020. We do have interest rate exposure with respect to the $1,338.2 million balance of our variable interest rate debt outstanding as of July 3, 2020. A 50 basis point increase in interest rates, including the impact of interest rate swaps, would impact our expected annual interest expense for the next 12 months by approximately $8.6 million. However, some of this impact would be offset by additional interest earned on our cash and cash equivalents should rates on deposits and investments also increase. We entered into interest rate swaps to hedge some of the risk of variability in cash flows resulting from future interest payments on our variable interest rate debt under the Term Loan "B" Facility and Revolving Credit Facility.
While we have observed some recent stabilization in the capital markets impacted by the COVID-19 pandemic, there can be no assurance that equity or borrowings will be available when we access the capital markets or, if available, will be at rates or prices acceptable to us.
To ensure the adequacy and effectiveness of our foreign exchange hedge positions, we continually monitor our foreign exchange forward positions, both on a stand-alone basis and in conjunction with their underlying foreign currency exposures, from an accounting and economic perspective. However, given the inherent limitations of forecasting and the anticipatory nature of exposures intended to be hedged, we cannot provide any assurances that such programs will offset more than a portion of the adverse financial impact resulting from unfavorable movements in foreign exchange rates.
We are subject to risks associated with transactions that are denominated in currencies other than our functional currencies, as well as the effects of translating amounts denominated in a foreign currency to the U.S. Dollar as a normal part of the reportable process. Some of our Japanese operations utilize Japanese Yen as the functional currency, which results in a translation adjustment that is included as a component of accumulated other comprehensive income.
We enter into forward foreign currency contracts that economically hedge the gains and losses generated by the re-measurement of certain recorded assets and liabilities in a non-functional currency. Changes in the fair value of these undesignated hedges are recognized in other income and expense immediately as an offset to the changes in the fair value of the assets or liabilities being hedged. The notional amount of foreign exchange contracts at July 3, 2020 and December 31, 2019 was $172.5 million and $183.3 million, respectively. Our policies prohibit speculation on financial instruments, trading in currencies for which there are no underlying exposures or entering into trades for any currency to intentionally increase the underlying exposure.
Substantially all of our revenue is transacted in U.S. Dollars. However, a significant amount of our operating expenditures and capital purchases are transacted in local currencies, including Japanese Yen, Euros, Korean Won, Malaysian Ringgit, Philippine Peso, Singapore Dollars, Swiss Francs, Chinese Renminbi and Czech Koruna. Due to the materiality of our transactions in these local currencies, our results are impacted by changes in currency exchange rates measured against the U.S. Dollar. For example, we determined that based on a hypothetical weighted-average change of 10% in currency exchange rates, our results would have impacted our income before taxes by approximately $60.6 million as of July 3, 2020, assuming no offsetting hedge positions or correlated activities.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act). Based upon that evaluation, our Chief Executive Officer and Chief
40
Financial Officer concluded that, as of the end of the period covered in this report, our disclosure controls and procedures were effective to ensure that information required to be disclosed in reports filed under the Exchange Act is recorded, processed, summarized and reported within the required time periods and is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
We also carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during the fiscal quarter ended July 3, 2020.
There have been no changes to our internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the fiscal quarter ended July 3, 2020, which have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
41
PART II: OTHER INFORMATION
Item 1. Legal Proceedings
See Note 10: ''Commitments and Contingencies'' under the heading "Legal Matters" in the notes to the consolidated unaudited financial statements included elsewhere in this Form 10-Q for a discussion of our legal proceedings and related matters. See also Part I, Item 1 "Business - Government Regulation" of the 2019 Form 10-K for information on certain environmental matters.
Item 1A. Risk Factors
Our business, financial condition and results of operations are subject to a number of trends, risks and uncertainties. We review and, where applicable, update our risk factors each quarter. There have been no material changes from the risk factors disclosed in Part I, Item 1A of the 2019 Form 10-K, other than the following:
The stockholders’ rights plan adopted by our Board of Directors may discourage a third party from acquiring us in a manner that might result in a premium price to our stockholders.
On June 7, 2020, our Board of Directors authorized and declared dividend of one authorized and declared a dividend of one preferred share purchase right (a “Right”) for each outstanding share of common stock. If a person or group of affiliated or associated persons acquires beneficial ownership of 15% or more of our then outstanding common stock, subject to certain exceptions, each Right would entitle its holder (other than the acquiring person or group of affiliated or associated persons) to purchase additional shares of our common stock at a substantial discount to the public market price. In addition, under certain circumstances, we may exchange the Rights (other than Rights beneficially owned by the acquiring person or group of affiliated or associated persons), in whole or in part, for shares of our common stock on a one-for-one basis. The stockholders’ rights plan could make it more difficult for a third party to acquire us or a large block of our common stock without the approval of our Board of Directors, which may discourage a third party from acquiring us in a manner that might result in a premium price to our stockholders.
The Company is subject to governmental laws, regulations and other legal obligations related to privacy and data protection.
The legislative and regulatory framework for privacy and data protection issues worldwide is rapidly evolving and is likely to remain uncertain for the foreseeable future. The Company collects personally identifiable information (“PII”) and other data as part of its business processes and activities. This data is subject to a variety of U.S. and international laws and regulations, including oversight by various regulatory or other governmental bodies. Many foreign countries and governmental bodies, including the European Union and other relevant jurisdictions where the Company conducts business, have laws and regulations concerning the collection and use of PII and other data obtained from their residents or by businesses operating within their jurisdictions that are currently more restrictive than those in the U.S. Additionally, in May 2016, the European Union adopted the General Data Protection Regulation that imposed more stringent data protection requirements and provided for greater penalties for noncompliance beginning in May 2018. In addition, among other applicable laws, California adopted significant new consumer privacy laws in June 2018 that became effective on January 1, 2020 and Thailand adopted the Personal Data Protection Act B.E. 2562 in May 2019. In addition, from time to time our global operations may require importing, exporting or transferring data across international borders in compliance with both U.S. customs and export control regulations, including the Export Administration Regulations and the International Traffic in Arms Regulations. Any inability, or perceived inability, to adequately address privacy and data protection concerns, even if unfounded, or to comply with applicable laws, regulations, policies, industry standards, contractual obligations or other legal obligations, could result in additional cost and liability to the Company or company officials, including substantial monetary fines, and could damage our reputation, inhibit sales and adversely affect our business.
The effects of the COVID-19 pandemic have had, and could continue to have, an adverse impact on our business, results of operations and financial condition.
Our business has been, and is expected to continue to be, adversely impacted by the effects of the COVID-19 pandemic. In addition to global macroeconomic effects, the COVID-19 pandemic and related adverse public health developments have been causing, and are expected to continue to cause, disruption to our domestic and international operations and sales activities. In addition, we and our suppliers, third-party distributors, sub-contractors and customers have been, and are expected to continue to be, disrupted by worker absenteeism, quarantines and restrictions on certain of our employees’ ability to perform their jobs, office and factory closures or restrictions, disruptions to ports and other shipping infrastructure, border closures or other travel or health-related restrictions. Depending on the magnitude of such effects on our manufacturing, assembling and testing activities or the operations of our suppliers, third-party distributors or sub-contractors, our supply chain, manufacturing and product shipments are expected to continue to be delayed, which could materially adversely affect our business, results of operations and financial condition. In addition, the COVID-19 pandemic or other disease outbreaks will, in the short-term, and
42
could over the longer term, adversely affect the economies and financial markets of many countries, resulting in an economic downturn or recession that could adversely affect demand for our products and impact our results of operations and financial condition. There can be no assurance that any decrease in sales resulting from the COVID-19 pandemic will be offset by increased sales in subsequent periods. These effects, alone or taken together, could have a material adverse effect on our business, results of operations, legal exposure, or financial condition. The extent of the COVID-19 pandemic’s effect on our operational and financial performance will depend on future developments, including the duration, spread and intensity of the pandemic, all of which are uncertain and difficult to predict. Due to the speed with which the situation is developing, we are not able at this time to estimate the long-term effect of these factors on our business, but the adverse impact on our business, results of operations, financial condition and cash flows has been, and could continue to be, material.
Business disruptions resulting from the COVID-19 pandemic have caused, and could continue to cause, significant harm to our business operations and facilities and have had, and could continue to have, a material adverse effect on our supply chain, customer base, business, results of operations and financial condition.
Our U.S. and international manufacturing facilities and distribution centers, as well as the operations of our third-party suppliers, are susceptible to losses and interruptions caused by floods, hurricanes, earthquakes, typhoons, and similar natural disasters, as well as power outages, telecommunications failures, industrial accidents, health and safety epidemics, including the COVID-19 pandemic, and similar events. The occurrence of these or other events in any of the regions in which we operate could severely disrupt the operations of our businesses by negatively impacting our supply chain, our ability to deliver products, and the cost of our products. For example, as a result of the outbreak of the COVID-19 pandemic during 2020, we and/or certain of our third party vendors have experienced, and may continue to experience decreased production in some of our facilities, which have led, and may continue to lead, to interruptions in our supply chain, delays in delivery of or inability to deliver products on expected timeframes or at all, and/or loss of customers. Disruptions caused by the COVID-19 pandemic have adversely affected, and may continue to adversely affect, our revenue, earnings and cash flow, both from decreased revenue and from increased costs associated with the COVID-19 pandemic. In addition, these events have caused, and could continue to cause, consumer confidence and spending to decrease and increased volatility to the U.S. and worldwide economies. Although we carry insurance to generally compensate for losses of the type noted above, such insurance may not be adequate to cover all losses that may be incurred or continue to be available in the affected area at commercially reasonable rates and terms. To the extent any losses from the COVID-19 pandemic, other health pandemics, natural disasters or other business disruptions are not covered by insurance, any costs, write-downs, impairments and decreased revenue can materially adversely affect our business, our results of operations and our financial condition.
Many of our facilities and processes are interdependent and an operational disruption at any particular facility could have a material adverse effect on our ability to produce many of our products, which could materially adversely affect our business and results of operations.
We utilize an integrated manufacturing platform in which multiple facilities may each produce one or more components necessary for the assembly of a single product. As a result of the necessary interdependence within our network of manufacturing facilities, an operational disruption at a facility toward the front-end of our manufacturing process may have a disproportionate impact on our ability to produce many of our products. For example, our facility in Rožnov pod Radhoštěm, Czech Republic, manufactures silicon wafers used by a number of our facilities, and ISG relies predominantly on one third-party for manufacturing at the front-end of its manufacturing process, and any operational disruption, including any future travel bans or restrictions, quarantines, shelter-in-place orders, or shutdowns as a result of the COVID-19 pandemic, any natural or man-made disaster or other extraordinary event that impacted either of those facilities would have a material adverse effect on our ability to produce a number of our products worldwide. In the event of a disruption at any such facility, we may be unable to effectively source replacement components on acceptable terms from qualified third parties, in which case our ability to produce many of our products could be materially disrupted or delayed. Conversely, many of our facilities are single source facilities that only produce one of our end-products, and a disruption at any such facility would materially delay or cease production of the related product. In the event of any such operational disruption, we may experience difficulty in beginning production of replacement components or products at new facilities (for example, due to construction delays) or transferring production to other existing facilities (for example, due to capacity constraints or difficulty in transitioning to new manufacturing processes), any of which could result in a loss of future revenues and materially adversely affect our business and results of operations.
Downturns or volatility in general economic conditions could have a material adverse effect on our business and results of operations.
In recent years, worldwide semiconductor industry sales have tracked the impact of the financial crisis, subsequent recovery and persistent economic uncertainty. We believe that the state of global economic conditions are particularly volatile and uncertain, not only in light of the COVID-19 pandemic and the potential global recession resulting therefrom, but also due to recent and expected shifts in political, legislative and regulatory conditions concerning, among other matters, international trade and
43
taxation, and that an uneven recovery or a renewed global downturn may put pressure on our sales due to reductions in customer demand as well as customers deferring purchases. Volatile or uncertain economic conditions, as well as continuing political unrest in markets in which we conduct significant business, including Hong Kong, can adversely impact sales and profitability and make it difficult for us and our competitors to accurately forecast and plan our future business activities.
Historically, the semiconductor industry has been highly cyclical and, as a result, subject to significant downturns and upturns in customer demand for semiconductors and related products. We believe our business today is driven more by secular growth drivers and not solely by macroeconomic and industry cyclicality, as was the case historically. As we did in 2019, we could again experience period-to-period fluctuations in operating results due to general industry or economic conditions. We cannot accurately predict the timing of future downturns and upturns in the semiconductor industry or how severe and prolonged these conditions might be. Significant downturns often occur in connection with, or in anticipation of, maturing product cycles (for semiconductors and for the end-user products in which they are used) or declines in general economic conditions and can result in reduced product demand, production overcapacity, high inventory levels and accelerated erosion of average selling prices, any of which could materially adversely affect our operating results as a result of increased operating expenses outpacing decreased revenue, reduced margins, underutilization of our manufacturing capacity and/or asset impairment charges. On the other hand, significant upturns can cause us to be unable to satisfy demand in a timely and cost efficient manner. In the event of such an upturn, we may not be able to expand our workforce and operations in a sufficiently timely manner, procure adequate resources and raw materials, or locate suitable third-party suppliers to respond effectively to changes in demand for our existing products or to the demand for new products requested by our customers, and our business and results of operations could be materially and adversely affected.
To the extent we incorrectly plan for favorable economic conditions that do not materialize or take longer to materialize than expected, we may face oversupply of our products relative to customer demand. In the past, reduced customer spending has driven us, and may in the future drive us and our competitors, to reduce product pricing, which results in a negative effect on gross profit. Moreover, volatility in revenue as a result of unpredictable economic conditions, including, but not limited to, the worsening of economic conditions due to the COVID-19 pandemic, may alter our anticipated working capital needs and interfere with our short-term and long-term strategies. To the extent that our sales, profitability and strategies are negatively affected by downturns or volatility in general economic conditions, our business and results of operations may be materially adversely affected.
Our substantial debt could materially adversely affect our financial condition and results of operations.
As of December 31, 2019, we had $3,749.2 million of outstanding indebtedness. We may need to incur additional indebtedness in the future to repay or refinance other outstanding debt, to make acquisitions or for other purposes, and if we incur additional debt, the related risks that we now face could intensify. For example, on March 24, 2020, as a precautionary measure in order to increase our cash position and facilitate financial flexibility in light of uncertainty resulting from the COVID-19 pandemic, we borrowed an additional $1,165.0 million under the Revolving Credit Facility, as a result of which we have currently borrowed substantially all of the amount available under the Revolving Credit Facility. As of the date of this Form 10-Q, we have $4.0 million available under the Revolving Credit Facility, subject to certain conditions. The degree to which we are leveraged could have important consequences to our potential and current investors, including:
•our ability to obtain additional financing in the future for working capital, capital expenditures, acquisitions, general corporate purposes or other purposes may be impaired;
•the timing, amount and execution of our capital allocation policy, including our 2018 Share Repurchase Program, could be affected by the degree to which we are leveraged;
•a significant portion of our cash flow from operating activities must be dedicated to the payment of interest and principal on our debt, which reduces the funds available to us for our operations and may limit our ability to engage in acts that may be in our long-term best interests;
•some of our debt is and will continue to be at variable rates of interest, which may result in higher interest expense in the event of increases in market interest rates;
•our debt agreements may contain, and any agreements to refinance our debt likely will contain, financial and restrictive covenants, and our failure to comply with them may result in an event of default which if not cured or waived, could have a material adverse effect on us;
•our level of indebtedness will increase our vulnerability to, and reduce our flexibility to respond to, general economic downturns and adverse industry and business conditions, including as a result of the COVID-19 pandemic;
•as our long-term debt ages, we must repay, and may need to renegotiate, such debt or seek additional financing;
•to the extent the debt we incur requires collateral to secure such indebtedness, our assets could be at risk and our flexibility related to such assets could be limited;
•our debt service obligations could limit our flexibility in planning for, or reacting to, changes in our business and the semiconductor industry;
44
•our substantial leverage could place us at a competitive disadvantage vis-à-vis our competitors who may have less leverage relative to their overall capital structures; and
•our level of indebtedness may place us at a competitive disadvantage relative to less leveraged competitors.
To the extent that we continue to maintain or expand our significant indebtedness, our financial condition and results of operations may be materially adversely affected. Additionally, we may not be able to access cash or to incur additional indebtedness if the ongoing macroeconomic effects of the COVID-19 pandemic, including certain actions taken by U.S. or other governmental authorities, such as decreases in short-term interest rates as announced by the Federal Reserve, cause the closure of banks for an extended period of time or a sudden increase in requests for indebtedness at one time by many potential borrowers, either or both of which could overwhelm the banking industry.
If our operating subsidiaries, which may have no independent obligation to repay our debt, are not able to make cash available to us for such repayment, our business, financial condition and results of operations may be adversely affected.
We conduct our operations through our subsidiaries. Repayment of our indebtedness is dependent on the generation of cash flow by our subsidiaries and their ability to make such cash available to us, by dividend, debt repayment or otherwise. Unless they are guarantors of our indebtedness, our subsidiaries have no obligation to pay amounts due on such indebtedness or to make funds available for that purpose. Our subsidiaries may not be able to, or may not be permitted to, make distributions to enable us to make payments in respect of our indebtedness. Each subsidiary is a distinct legal entity, and, under certain circumstances, legal, contractual, governmental or regulatory restrictions may limit our ability to obtain cash from our subsidiaries. In the event that we do not receive distributions or payments from our subsidiaries, we may be unable to make required principal and interest payments on our indebtedness and, as described above, any inability to repay our debt when due would have a material adverse effect on our business, financial condition and results of operations.
If interest rates increase, our debt service obligations under our variable rate indebtedness could increase significantly, which would have a material adverse effect on our results of operations.
Borrowings under certain of our facilities from time to time, including under our Amended Credit Agreement, are at variable rates of interest and as a result expose us to interest rate risk. If interest rates were to increase, our debt service obligations on the variable rate indebtedness would increase even though the amount borrowed remained the same, and our net income and cash flows, including cash available for servicing our indebtedness, will correspondingly decrease. During the first quarters of 2017 and 2019 and the second quarter of 2020, we entered into interest rate swaps that involved the exchange of floating for fixed rate interest payments in order to reduce interest rate volatility for a portion of our Term Loan “B” Facility and our Revolving Credit Facility through the end of 2022. However, we may not maintain interest rate swaps with respect to all of our variable rate indebtedness, and any swaps we enter into may not fully mitigate our interest rate risk. To the extent the risk materializes and is not fully mitigated, the resulting increase in interest expense could have a material adverse effect on our results of operations.
Some of our current debt and related agreements, including the Amended Credit Agreement and our interest rate swap agreements, have an interest rate tied to LIBO Rate, which is expected to be discontinued after 2021. While certain of these agreements, such as the Amended Credit Agreement, provide procedures for determining an alternative base rate in the event that LIBO Rate is discontinued, not all do so. Regardless, there can be no assurances as to what alternative base rates may be and whether such base rate will be more or less favorable than LIBO Rate and any other unforeseen impacts of the potential discontinuation of LIBO Rate. The Company intends to monitor the developments with respect to the potential phasing out of LIBO Rate after 2021 and work with its lenders to ensure any transition away from LIBO Rate will have minimal impact on its financial condition, but can provide no assurances that the impact of the discontinuation of LIBO Rate would not have a material adverse effect on our results of operations.
Forward-Looking Statements
This Quarterly Report on Form 10-Q includes “forward-looking statements,” as that term is defined in Section 27A of the Securities Act and Section 21E of the Exchange Act. All statements, other than statements of historical facts, included or incorporated in this Form 10-Q could be deemed forward-looking statements, particularly statements about our plans, strategies and prospects under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Forward-looking statements are often characterized by the use of words such as “believes,” “estimates,” “expects,” “projects,” “may,” “will,” “intends,” “plans,” or “anticipates,” or by discussions of strategy, plans or intentions. All forward-looking statements in this Form 10-Q are made based on our current expectations, forecasts, estimates and assumptions and involve risks, uncertainties and other factors that could cause results or events to differ materially from those expressed in the forward-
45
looking statements. Among these factors are our revenue and operating performance; economic conditions and markets (including current financial conditions); risk related to changes in tariffs or other government trade policies, including between the U.S. and China; risks related to our ability to meet our assumptions regarding outlook for revenue and gross margin as a percentage of revenue; effects of exchange rate fluctuations; the cyclical nature of the semiconductor industry; changes in demand for our products; changes in inventories at our customers and distributors; risks associated with restructuring actions and workforce reductions; technological and product development risks; risks that our products may be accused of infringing the IP rights of others; enforcement and protection of our IP rights and related risks; risks related to the security of our information systems and secured network; availability of raw materials, electricity, gas, water and other supply chain uncertainties; our ability to effectively shift production to other facilities when required in order to maintain supply continuity for our customers; variable demand and the aggressive pricing environment for semiconductor products; our ability to successfully manufacture in increasing volumes on a cost-effective basis and with acceptable quality for our current products; risks associated with our acquisitions and dispositions generally, including our ability to realize the anticipated benefits of our acquisitions and dispositions, including our acquisition of Quantenna; risks that acquisitions or dispositions may disrupt our current plans and operations, the risk of unexpected costs, charges or expenses resulting from acquisitions or dispositions and difficulties arising from integrating and consolidating acquired businesses, our timely filing of financial information with the SEC for acquired businesses and our ability to accurately predict the future financial performance of acquired businesses; competitor actions, including the adverse impact of competitor product announcements; pricing and gross profit pressures; risks associated with the addition of Huawei Technologies Co., Ltd. and its non-U.S. affiliates and subsidiaries, and other customers, to the U.S. Department of Commerce, Bureau of Industry Security Entity List; loss of key customers; order cancellations or reduced bookings; changes in manufacturing yields; control of costs and expenses and realization of cost savings and synergies from restructurings; the costs to defend against or pursue litigation and the potential significant costs associated with adverse litigation outcomes; risks associated with decisions to expend cash reserves for various uses in accordance with our capital allocation policy such as debt prepayment, stock repurchases or acquisitions rather than to retain such cash for future needs; risks associated with our substantial leverage and restrictive covenants in our debt agreements that may be in place from time to time; risks associated with our worldwide operations, including changes in trade policies, foreign employment and labor matters associated with unions and collective bargaining arrangements, continuing political unrest in markets in which we do significant business, including Hong Kong, as well as man-made and/or natural disasters, public health and safety outbreaks affecting our operations or financial results, including as a result of the outbreak of COVID-19; the threat or occurrence of international armed conflict and terrorist activities both in the United States and internationally; risks of changes in U.S. or international tax rates or legislation; risks and costs associated with increased and new regulation of corporate governance and disclosure standards; risks related to new legal requirements; risks related to the potential impact of climate change and regulations related thereto on our operations; and risks and expenses involving environmental or other governmental regulation. Readers are cautioned not to place undue reliance on forward-looking statements. We assume no obligation to update such information, except as may be required by law. Additional factors that could affect our future results or events are described under Part I, Item 1A “Risk Factors” in the 2019 Form 10-K, in this Form 10-Q, and from time to time in our other SEC reports. You should carefully consider the trends, risks and uncertainties described in this Form 10-Q, Part I, Item 1A “Risk Factors” in the 2019 Form 10-K, Part II, and subsequent reports filed with or furnished to the SEC before making any investment decision with respect to our securities. If any of the following trends, risks or uncertainties actually occurs or continues, our business, financial condition or operating results could be materially adversely affected, the trading prices of our securities could decline and you could lose all or part of your investment. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by this cautionary statement.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table provides information regarding repurchases of our common stock during the quarter ended July 3, 2020:
Period (1) | Total Number of Shares Purchased (2) | Average Price Paid per Share ($) (3) | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Approximate Dollar value of Shares that May Yet be Purchased Under the Plans or Programs (in millions) ($) | ||||||||||||||||||||||
| April 4, 2020 - May 1, 2020 | 4,758 | 15.11 | — | 1,295.8 | ||||||||||||||||||||||
| May 2, 2020 - May 29, 2020 | 7,139 | 15.73 | — | 1,295.8 | ||||||||||||||||||||||
| May 30, 2020 - July 3, 2020 | 19,783 | 19.11 | — | 1,295.8 | ||||||||||||||||||||||
| Total | 31,680 | 17.75 | — | |||||||||||||||||||||||
(1) These time periods represent our fiscal month start and end dates for the second quarter of 2020.
46
(2) The number of shares purchased represents shares of common stock held by employees who tendered owned shares of common stock to the Company to satisfy the employee withholding taxes due upon the vesting of RSUs and shares purchased under the Share Repurchase Program.
(3) The price per share is based on the fair market value at the time of tender or repurchase, respectively.
Share Repurchase Program
During the quarter ended July 3, 2020, we repurchased no shares of our common stock under the Share Repurchase Program.
Under the Share Repurchase Program, we may repurchase up to $1.5 billion (exclusive of fees, commissions and other expenses) of our common stock from December 1, 2018 through December 31, 2022, subject to certain contingencies. We may repurchase our common stock from time to time in privately negotiated transactions or open market transactions, including pursuant to a trading plan in accordance with Rule 10b5-1 and Rule 10b-18 of the Exchange Act, or by any combination of such methods or other methods. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, restrictions under our debt obligations, the availability of capital and other market and economic conditions. The Share Repurchase Program does not require us to purchase any particular amount of common stock and is subject to a variety of factors including the discretion of our board of directors. As of July 3, 2020, the authorized amount remaining under the Share Repurchase Program was $1,295.8 million.
See Note 8: ''Earnings Per Share and Equity'' of the notes to our unaudited consolidated financial statements included elsewhere in this Form 10-Q for further information on shares of common stock tendered to the Company by employees to satisfy applicable employee withholding taxes due upon vesting of RSUs and the Share Repurchase Program.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
None.
47
Item 6. Exhibits
EXHIBIT INDEX
| Exhibit No. | Exhibit Description* | ||||||||||||||||||||||||||||
| 3.1 | |||||||||||||||||||||||||||||
| 4.1 | |||||||||||||||||||||||||||||
| 10.1 | |||||||||||||||||||||||||||||
| 31.1 | |||||||||||||||||||||||||||||
| 31.2 | |||||||||||||||||||||||||||||
| 32 | |||||||||||||||||||||||||||||
| 101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.(1) | ||||||||||||||||||||||||||||
| 101.SCH | XBRL Taxonomy Extension Schema Document(1) | ||||||||||||||||||||||||||||
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document(1) | ||||||||||||||||||||||||||||
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document(1) | ||||||||||||||||||||||||||||
| 101.LAB | XBRL Taxonomy Extension Label Linkbase Document(1) | ||||||||||||||||||||||||||||
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document(1) | ||||||||||||||||||||||||||||
| 104 | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. | ||||||||||||||||||||||||||||
* | Reports filed under the Exchange Act (Form 10-K, Form 10-Q and Form 8-K) are filed under File No. 000-30419. | ||||
(1) | Filed herewith. | ||||
(2) | Furnished herewith. | ||||
48
SIGNATURES
Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| ON SEMICONDUCTOR CORPORATION (Registrant) | ||||||||||||||
| Date: | August 10, 2020 | By: | /s/ BERNARD GUTMANN | |||||||||||
| Bernard Gutmann | ||||||||||||||
Executive Vice President, Chief Financial Officer & Treasurer | ||||||||||||||
(Principal Financial Officer and officer duly authorized to sign this report) | ||||||||||||||
| By: | /s/ BERNARD R. COLPITTS JR. | |||||||||||||
| Bernard R. Colpitts Jr. | ||||||||||||||
| Chief Accounting Officer | ||||||||||||||
| (Principal Accounting Officer and officer duly authorized to sign this report) | ||||||||||||||
49
Exhibit 31.1
CERTIFICATIONS
I, Keith D. Jackson, certify that:
1.I have reviewed this quarterly report on Form 10-Q of ON Semiconductor Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
| Date: August 10, 2020 | /s/ KEITH D. JACKSON | ||||
| Keith D. Jackson | |||||
| Chief Executive Officer | |||||
232944v2
Exhibit 31.2
CERTIFICATIONS
I, Bernard Gutmann, certify that:
1. I have reviewed this quarterly report on Form 10-Q of ON Semiconductor Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
| Date: August 10, 2020 | /s/ BERNARD GUTMANN | ||||
| Bernard Gutmann | |||||
| Chief Financial Officer | |||||
232945v2
Exhibit 32
Certification
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002
For purposes of Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of ON Semiconductor Corporation, a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report on Form 10-Q for the fiscal quarter ended July 3, 2020 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)) and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: August 10, 2020 | /s/ KEITH D. JACKSON | ||||
| Keith D. Jackson | |||||
| President and Chief Executive Officer | |||||
| Dated: August 10, 2020 | /s/ BERNARD GUTMANN | ||||
| Bernard Gutmann | |||||
| Executive Vice President, | |||||
| Chief Financial Officer, and | |||||
| Treasurer | |||||
232946v2